UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number 811-07986

The Alger Institutional Funds
(Exact name of registrant as specified in charter)

100 Pearl Street, New York, New York 10004
(Address of principal executive offices) (Zip code)

Mr. Hal Liebes
Fred Alger Management, LLC
100 Pearl Street
New York, New York 10004
(Name and address of agent for service)

Registrant’s telephone number, including area code: 212-806-8800

Date of fiscal year end: October 31

Date of reporting period: April 30, 2022

Form N-CSR is to be used by management investment companies to file reports with the Commission, not later than 10 days after the transmission to Stockholders of any report to be transmitted to Stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e1).  The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public.  A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.



ITEM 1.
REPORT(S) TO STOCKHOLDERS.

(a)
The following is a copy of the report transmitted to shareholders pursuant to Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1).




Table of Contents
 
   
The Alger Institutional Funds
 
   
 1
   
 12
   
 20
   
 21
   
 37
   
 41
   
43
   
Financial Highlights
 47
   
Notes to Financial Statements  62
   
Additional Information  89


Dear Shareholders,
 
Many Investors Shun Powerful Wealth Creator
In 1924, economist John Maynard  Keynes wrote that  companies that  reinvest profits  can create “an element of compound interest operating in favour of a sound industrial investment." At Alger, we believe reinvesting profits and producing compounding earnings growth is a powerful wealth creator. To that end, we seek companies that we believe have strong potential for compounding earnings growth, and we seek to avoid cyclical companies, including “short-duration” companies, or businesses with high current earnings that return most of their profits to shareholders. In most instances, these cyclical companies, in our view, have little or no potential for future long-term earnings growth.
 
As Warren Buffett has observed, investors “occasionally do crazy things,” which creates opportunities for investors who can “disregard mob fears or enthusiasms….and focus    on a few simple fundamentals." We believe recent concerns about interest rates, inflation and valuations have caused many investors to act irrationally by focusing on cyclical short- duration companies while shunning the "sound industrial investment" identified by Keynes.
 
Setting the Stage for a Difficult Six-Month Period
The strong trend of investors rejecting the appeal of long-term earnings growth, in our view, played a major role in our disappointing fund performance during the fiscal six-month period ended April 30, 2022. The fiscal period included the continuation of a dramatic rotation by many investors seeking instant gratification by favoring companies with high current earnings. This rotation was initially fueled prior to the reporting period by optimism that scaling back or eliminating measures to curtail the COVID-19 pandemic combined with unprecedented levels of fiscal stimulus would drive strong economic growth. More recently, however, optimism gave way to concerns that equities may be overvalued at a time when the economy could overheat and require the U.S. Federal Reserve (the “Fed”) to continue to raise interest rates to fight inflation.
 
These concerns were supported by the following developments:
 

U.S. gross domestic product (“GDP”), which declined 3.4% in 2020 due to the economy shutting down to contain the pandemic, jumped 5.7% in 2021.
 

After climbing to 6.3% at the end of 2020, the seasonally adjusted unemployment rate declined to 4.2% as of the November 2021 start of the fiscal six-month reporting period. It eventually reached 3.6% as of the end of the six-month period, during which concerns about inflation grew, a result of a tight labor market, among other things.


Data appeared to validate inflation concerns. After hitting a 6.8% year-over- year increase (or increase during the past 12-month period) in November 2021 and increasing each subsequent month, the Consumer Price Index hit 8.5% as of March 2022.

- 1 -

In  response,  the  Fed  shifted  its  outlook-it  no  longer  maintained  that  inflation  was a transitory result of  supply chain issues and the economy reopening, and in March, the Fed raised the federal funds rate by 25 basis points ("BPS"), its first hike since cutting the rate to zero in 2020. Furthermore, Fed statements in March led many investors to anticipate a 50BPS rate hike in May and 200BPS in aggregate hikes by the end of 2022. Fears that rate hikes could eventually spark a recession also weighed upon investor sentiment.
 
Interest Rates Support Rotation Away from Quality
The rotation to short-duration companies was also partially supported by investors reacting to higher interest rates in a fairly typical fashion-they adjusted their cash flow modeling   by increasing the rate at which they discount future cash flows back to the present, thereby lowering the value of long-duration companies. This process is similar to how long-term bonds are impacted more by rising rates than short-term bonds.
 
Not Just Growth, But High-Quality Small Cap Growth, Underperforms
Many small cap growth companies tend to have little or no current earnings, but strong potential for significant sales and earnings growth. Within the Russell 2000 Growth Index, for example, we believe many Healthcare companies are high-quality businesses even though they may not generate profits due to their investments in new initiatives, their products or potential products can have high gross margins and potential for capturing market share.
As a result of investors dismissing the appeal of potential earnings growth, the Healthcare sector was one of the worst performing sectors within the small cap growth category. From a broader perspective, sectors that generally consist of companies that provide dividends and appear to be less susceptible to inflation, such as Energy and Consumer Staples, led.
 
Also during the fiscal six-month period, growth underperformed value across the market cap spectrum, with the -26.77% return of the Russell 2000 Growth Index being a noteworthy laggard when compared to the -9.5% return of the Russell 2000 Value Index. The broad market, as measured by the S&P 500 Index, dropped 8.17%.
 
International Markets Also Struggle
Concerns about interest rates, inflation and the Russian invasion of Ukraine also extended beyond the U.S. Investors also assessed the spread of COVID-19 in China. Among non-U.S. equities, emerging markets significantly underperformed with the MSCI Emerging Markets Index declining 14.04% during the fiscal six-month reporting period. Within the index, the Utilities sector was the only sector to generate positive performance, as investors focused on companies that they perceived as having recession resistant fundamentals that provide a relatively high return of cash to shareholders. Consumer Discretionary, Healthcare and Energy were among the worst performing sectors. The selloff also included developed markets with the MSCI EAFE Index declining 11.58%. From a broader perspective, the MSCI ACWI Index declined 11.45%.
 
Irrational Behavior Creates Opportunity
As a result of investors’ rotation out of quality companies, growth equities, we believe, are trading at attractive valuations. Notably, the Russell 2000 Growth Index price-to-earnings (P/E) ratio based on the next 12-months' earnings, declined from 50.2x to approximately 33.5x during the six-month fiscal reporting period while the Russell 1000 Growth Index declined from 30.7x to 23.8x.
 
Navigating Fed Rate Hikes
Investors who are concerned about monetary policy may want to consider two points:

- 2 -

First, Fed rate increases don’t always lead to recessions. In fact, since 1965 there have been three instances in which the Fed increased the federal funds rate 300 BPS or more that resulted in continued real economic growth and slowing inflation rather than recessions. Additionally, during the 12-months following the end of Fed tightening in 1985 and 1995, as well as after the Fed relented in 2018, equities generated double-digit returns.
 
Second, the later phases of monetary tightening have been accompanied by growth stocks outperforming value equities. The six-month periods starting approximately three months after the beginning of Fed tightening cycles initiated in 1994, 1999, 2004, and 2015 illustrate this point. Based on the returns of the Russell 3000 Growth and Russell 3000 Value indices, the median outperformance of growth during those periods was 400BPS. During later phases of rate hikes, economic growth slows, so investors may be more willing to pay a premium for companies that can increase their earnings.
 
Going Forward
We continue to believe that unprecedented levels of innovation, such as healthcare advancements in genetic science, and digital technologies including artificial intelligence, e-commerce, the metaverse, streaming entertainment, and cloud computing are providing opportunities for leading companies to reward investors by generating long-term earnings growth. We will continue to focus on conducting in-depth fundamental research as we seek leaders of innovation rather than take short-term bets on the fickle nature of investor sentiment. We believe doing so is the best strategy for helping our valued shareholders reach their investment goals.
 
Portfolio Matters
Alger Capital Appreciation Institutional Fund
The Alger Capital Appreciation Institutional Fund returned -26.65% for the fiscal six- month period ended April 30, 2022, compared to the -17.84% return of its benchmark, the Russell 1000 Growth Index.
 
During the reporting period, the largest portfolio sector weightings were Information Technology and Consumer Discretionary. The largest sector overweight was Information Technology and the largest sector underweight was Consumer Staples.
 
Contributors to Performance
The Communication Services and Real Estate sectors provided the largest contributions to relative performance during the reporting period. Regarding individual positions, Alibaba Group Holding Ltd. Sponsored ADR; AbbVie, Inc.; UnitedHealth Group Inc.; Vertex Pharmaceuticals Inc.; and Qualcomm, Inc. were among the top contributors to absolute performance. Alibaba is a leading e-commerce and cloud computing company in China.   It also serves the big data analytics, digital media and entertainment markets. Alibaba’s shares have previously suffered from concerns about heightened regulatory oversight of the Chinese internet sector by the Chinese Communist Party. Additionally, many investors became concerned about the potential for U.S. exchange listed Chinese ADRs to be delisted if they failed to meet U.S. financial reporting standards by 2024. These issues caused investors to sell shares of Alibaba, which we believe created attractive valuations. In the later portion of the fiscal six-month reporting period, the shares outperformed in response to statements by the Chinese government supporting stable markets and overseas listings. The Chinese government also stated that its intensified regulatory efforts aimed at tech companies may end soon.

- 3 -

Detractors from Performance
The Information Technology and Financial sectors were among the sectors that detracted from relative performance during the reporting period. Regarding individual positions, Amazon.com, Inc.; Microsoft Corp.; Shopify, Inc., Cl. A; Alphabet, Inc., Cl. C; and PayPal Holdings, Inc. were the top detractors from absolute performance. Microsoft is a positive dynamic change beneficiary of corporate America's transformative digitization. In a previous earnings call, Microsoft's CEO expects that technology spending as a percent of GDP is likely to jump from about 5% today to 10% in a few years, and that Microsoft   will continue to take market share within the technology industry. Microsoft’s enterprise cloud product, Azure, is rapidly growing and accruing market share. Microsoft reported that Azure grew 46% in the quarter ended December 31, 2021, and the company’s total revenue growth exceeded 20%. Microsoft's share price declined despite its high unit volume growth as the broad equity market and technology stocks declined due to higher interest rates and the Russia/Ukraine conflict.
 
Alger Focus Equity Fund
The Alger Focus Equity Fund returned -25.17% for the fiscal six-month period ended April 30, 2022, compared to the -17.84% return of its benchmark, the Russell 1000 Growth Index.
 
During the reporting period, the largest sector weightings were Information Technology and Consumer Discretionary. The largest sector overweight was Communication Services and the largest sector underweight was Consumer Staples.
 
Contributors to Performance
The Communication Services and Real Estate sectors provided the greatest contributions to relative performance during the reporting period. Regarding individual positions, Alibaba Group Holding Ltd. Sponsored ADR; UnitedHealth Group, Inc.; Qualcomm, Inc.; Starbucks Corp.; and Xilinx, Inc. were the top contributors to absolute performance. Shares of Alibaba outperformed in response to developments identified in the Alger Capital Appreciation Institutional Fund discussion.
 
Detractors from Performance
The Information Technology and Financials sectors were among the sectors that detracted from relative performance during the reporting period. Regarding individual positions, Amazon.com, Inc.; Microsoft Corp.; Shopify, Inc., Cl. A; Intuit, Inc.; and Alphabet, Inc., Cl. C were the most significant detractors from absolute performance. Shares of Microsoft underperformed in response to developments identified in the Alger Capital Appreciation Institutional Fund discussion.
 
Alger Mid Cap Growth Institutional Fund
The Alger Mid Cap Growth Institutional Fund returned -34.74% for the fiscal six-month period ended April 30, 2022, compared to the -25.44% return of its benchmark, the Russell Midcap Growth Index.
 
During the reporting period, the largest sector weightings were Information Technology and Healthcare. The largest sector overweight was Energy and the largest underweight was Industrial.

- 4 -

Contributors to Performance
The Consumer Discretionary and Real Estate sectors provided the largest contributions to relative performance during the reporting period.
 
Regarding individual positions, Diamondback Energy, Inc.; Palo Alto Networks, Inc.;   Vail Resorts, Inc.; Lucid Group, Inc.; and Xilinx, Inc. were among the top contributors to absolute performance. Vail Resorts is a premier luxury mountain resort operator whose properties include locations in Vail, Breckenridge, Beaver Creek, Park City, and Whistler. Given its strong industry position, shares of Vail Resorts positively contributed to portfolio performance as it capitalized on consumers’ embrace of travel and social activity as the economy reopened from pandemic restrictions.
 
Detractors from Performance
The Information Technology and Healthcare sectors were among the sectors that detracted from relative performance during the reporting period. Among individual positions, Upstart Holdings, Inc.; Natera, Inc.; Marqeta, Inc., Cl. A; Affirm Holdings, Inc., Cl. A; and Paycom Software, Inc. were among the most significant detractors from absolute performance. Natera is a specialty lab providing genetic testing services in reproductive health, oncology and transplant. Non-invasive prenatal testing (NIPT), part of the company’s reproductive health franchise, has generated the majority of revenue historically; however, we believe Natera's oncology business has potential to contribute toward a larger share of revenue as customers increasingly adopt these tests following positive insurance reimbursement decisions and favorable clinical trial results. Natera’s share underperformed after the publication of short report by Hindenburg Research. The company also lost a false advertisement lawsuit by CareDx, and high-growth, high-valuation companies were out of favor with many investors during the fiscal reporting period. We believe many of the allegations in the short report regarding sales and the company’s relationship with a third-party billing vendor are irrelevant to Natera’s outlook and its oncology franchise, which we view as the company’s key growth engine.
 
Alger Small Cap Growth Institutional Fund
The Alger Small Cap Growth Institutional Fund returned -34.99% for the fiscal six-month period ended April 30, 2022, compared to the -26.77% return of its benchmark, the Russell 2000 Growth Index.
 
During the reporting period, the largest portfolio sector weightings were Healthcare and Information Technology. The largest sector overweight was Healthcare and the largest underweight was Industrials.
 
Contributors to Performance
The Financials and Industrials sectors provided the largest contributions to relative performance during the reporting period. Regarding individual positions, Vocera Communications, Inc.; Magnolia Oil & Gas Corp., Cl. A; US Foods Holding Corp.; Chefs' Warehouse, Inc.; and HealthEquity, Inc. were among the top contributors to absolute performance. Vocera Communications is a leading provider of cloud-based communication and workflow solutions, primarily for the healthcare industry. Vocera's core solution is an enterprise-class server software platform that allows users to communicate and collaborate using voice or Health Insurance Portability and Accountability Act (HIPAA) compliant secure texting through a variety of  Vocera-designed and third-party devices. On January  6, 2022, Stryker Corp. announced an agreement to acquire Vocera for $79.25 per share, or an approximate $3.1 billion enterprise value, which was a 26.8% premium to the prior day's closing price. The deal was completed on February 23, 2022.

Detractors from Performance
The Information Technology and Healthcare sectors were among the sectors that detracted from relative performance during the reporting period. Regarding individual positions, InMode Ltd.; Joint Corp.; HubSpot, Inc.; Everbridge, Inc.; and Avalara, Inc. were among the top detractors from absolute performance. InMode designs, develops, manufactures and commercializes innovative minimally invasive and non-invasive aesthetic medical products. InMode’s platforms harness novel radio frequency (RF) technology for emerging minimally invasive procedures that bridge the gap between temporary treatments like facials and more invasive surgical procedures like facelifts across several specialty categories such as plastic surgery, gynecology, dermatology, ophthalmology and otolaryngology (ear, nose and throat care). The aesthetics market experienced strong tailwinds coming out of the COVID-19 pandemic. These tailwinds include the “Zoom effect,” or dissatisfaction with one’s personal appearance after viewing one’s own face on Zoom, which resulted in more people deciding to undergo aesthetic procedures. De-stigmatization of aesthetic procedures, aided by social media platforms, has also supported InMode's results. However, the stock price declined during the first quarter, in part due to a rotation out of high-valuation names. Some investors also feared a wallet share shift away from aesthetics and have concerns about InMode’s exposure to international markets due to the Ukraine/Russia conflict; however, our research suggests the company's revenue exposure to Europe is minimal.

I thank you for putting your trust in Alger.

Sincerely,

 
Daniel C. Chung, CFA
Chief Executive Officer
Fred Alger Management, LLC

Investors cannot invest directly in an index. Index performance does not reflect the deduction for fees, expenses or taxes.
 
This report and the financial statements contained herein are submitted for the general information of shareholders of the funds. This report is not authorized for distribution to prospective investors in a fund unless preceded or accompanied by an effective prospectus for the fund. Performance of funds discussed represents the return of Class I shares.
 
The performance data quoted represents past performance, which is not an indication or guarantee of future results.
Standardized performance results can be found on the following pages. The investment return and principal value of an investment in a fund will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted. For performance data current to the most recent month-end, visit us at www.alger.com, or call us at (800) 992-3863.

The views and opinions of the funds’ management in this report are as of the date of the Shareholders' Letter and are subject to change at any time subsequent to this date. There  is no guarantee that any of the assumptions that formed the basis for the opinions stated herein are accurate or that they will materialize. Moreover, the information forming the basis for such assumptions is from sources believed to be reliable; however, there is no guarantee that such information is accurate. Any securities mentioned, whether owned in a fund or otherwise, are considered in the context of the construction of an overall portfolio of securities and therefore reference to them should not be construed as a recommendation or offer to purchase or sell any such security. Inclusion of such securities in a fund and transactions in such securities, if any, may be for a variety of reasons, including, without limitation, in response to cash flows, inclusion in a benchmark, and risk control. The reference to a specific security should also be understood in such context and not viewed as a statement that the security is a significant holding in a fund. Please refer to the Schedule of Investments for each fund that is included in this report for a complete list of fund holdings as of April 30, 2022. Securities mentioned in the Shareholders' Letter, if not found in the Schedules of Investments, may have been held by the funds during the fiscal six-month period ended April 30, 2022.
 
Risk Disclosures
Alger Capital Appreciation Institutional Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional, or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of  companies in related sectors, and may  be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility.
 
Alger Focus Equity Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional, or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of  companies in related sectors, and may  be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Foreign securities involve special risks including currency fluctuations, inefficient trading, political, and economic instability, and increased volatility. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment.

Alger Mid Cap Growth Institutional Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of  companies in related sectors, and may  be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Investing in companies of medium capitalizations involve the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment.
 
Alger Small Cap Growth Institutional Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Investing in companies of small and medium capitalizations involve the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. At times, the Fund may hold a large cash position, which may underperform relative to equity securities.
 
For a more detailed discussion of the risks associated with a fund, please see the Prospectus.
 
Before investing, carefully consider a fund's investment objective, risks, charges, and expenses.
 
For a prospectus and summary prospectus containing this and other information  or for the Alger Institutional Funds' most recent month-end performance data, visit www.alger.com, call (800) 992-3863 or consult your financial advisor. Read the prospectus and summary prospectus carefully before investing.
 
Distributor: Fred Alger & Company, LLC.
 
NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE.

Definitions:
 

The Consumer Price Index is a measure of the average change over time in the prices paid by urban consumers for a market basket of consumer goods and services.
 

Price-to-earnings is the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
 

The Russell 3000 Growth Index combines the large-cap Russell 1000 Growth, the small-cap Russell 2000 Growth and the Russell Microcap Growth Index. It includes companies that are considered more growth oriented relative to the overall market as defined by Russell's leading style methodology. The Russell 3000 Growth Index is constructed to provide a comprehensive, un- biased, and stable barometer of the growth opportunities within the broad market.
 

The Russell 3000 Value Index measures the performance of the broad value segment of the US equity value universe. It includes those Russell 3000 companies with lower price-to-book ratios and lower forecasted growth values. The Russell 3000 Value Index is constructed to provide a comprehensive, unbiased and stable barometer of the broad value market.


The MSCI ACWI Index (gross) is a free float-adjusted market capitalization weighted index that is designed to measure the equity market performance of developed and emerging markets. The MSCI ACWI captures large and mid cap representation across developed markets and emerging markets countries.


The MSCI Emerging Markets Index (gross) is a free float-adjusted market capitalization index that is designed to measure equity market performance in the global emerging markets. The MSCI EAFE Index is designed to repre- sent the performance of large and mid-cap securities across developed mar- kets, including countries in Europe, Australasia and the Far East, excluding the U.S. and Canada.


The MSCI EAFE Index is designed to represent the performance of large and mid-cap securities across developed markets, including countries in Eu- rope, Australasia and the Far East, excluding the U.S. and Canada.
 

The Russell 1000 Growth Index measures the performance of the large-cap growth segment of the U.S. equity universe. It includes those Russell 1000 companies with higher growth earning potential as defined by Russell's lead- ing style methodology. The Russell 1000 Growth Index is constructed to provide a comprehensive and unbiased barometer for the large-cap growth segment.


The Russell Midcap Growth Index measures the performance of the mid- cap growth segment of the U.S. equity universe. It includes those Russell Midcap Index companies with higher growth earning potential as defined  by Russell's leading style methodology. The Russell Midcap Growth Index is constructed to provide a comprehensive and unbiased barometer of the mid-cap growth market.


The S&P 500 Index is an index of large company stocks considered to be representative of the U.S. stock market.
 

The Russell 2000 Growth Index measures the performance of the small- cap growth segment of the U.S. equity universe. It includes those Russell 2000 companies with higher growth earning potential as defined by Russell's leading style methodology. The Russell 2000 Growth Index is constructed to provide a comprehensive and unbiased barometer for the small-cap growth segment.


The Russell 2000 Value Index measures the performance of the small cap value segment of the U.S. equity universe. It includes those Russell 2000 companies with lower price-to-book ratios and lower forecasted growth values. The Russell 2000 Value Index is constructed to provide a comprehensive and unbiased barometer for the large-cap growth segment.

FUND PERFORMANCE AS OF 3/31/22 (Unaudited)
AVERAGE ANNUAL TOTAL RETURNS


 
1
YEAR
   
5
YEARS
   
10
YEARS
   
SINCE
INCEPTION
 
Alger Capital Appreciation Institutional Class I (Inception 11/8/93)
   
2.01
%
   
17.82
%
   
15.31
%
   
12.82
%
Alger Capital Appreciation Institutional Class R (Inception 1/27/03)*
   
1.56
%
   
17.29
%
   
14.78
%
   
12.27
%
Alger Capital Appreciation Institutional Class Y (Inception 2/28/17)
   
2.38
%
   
18.28
%
   
n/a
     
18.33
%
Alger Capital Appreciation Institutional Class Z-2 (Inception 10/14/16)
   
2.36
%
   
18.20
%
   
n/a
     
18.79
%
Alger Focus Equity Class A (Inception 12/31/12)
   
(2.73
)%
   
18.74
%
   
n/a
     
17.32
%
Alger Focus Equity Class C (Inception 12/31/12)
   
0.98
%
   
19.12
%
   
n/a
     
17.11
%
Alger Focus Equity Class I (Inception 11/8/93)
   
2.69
%
   
20.09
%
   
16.05
%
   
10.46
%
Alger Focus Equity Class Y (Inception 2/28/17)
   
3.02
%
   
20.47
%
   
n/a
     
20.55
%
Alger Focus Equity Class Z (Inception 12/31/12)
   
2.99
%
   
20.42
%
   
n/a
     
18.40
%
Alger Mid Cap Growth Institutional Class I (Inception 11/8/93)
   
(13.25
)%
   
15.39
%
   
13.17
%
   
12.21
%
Alger Mid Cap Growth Institutional Class R (Inception 1/27/03)*
   
(13.61
)%
   
14.85
%
   
12.60
%
   
11.65
%
Alger Mid Cap Growth Institutional Class Z-2 (Inception 10/14/16)
   
(12.92
)%
   
15.75
%
   
n/a
     
17.16
%
Alger Small Cap Growth Institutional Class I (Inception 11/8/93)
   
(20.97
)%
   
15.31
%
   
11.81
%
   
10.03
%
Alger Small Cap Growth Institutional Class R (Inception 1/27/03)*
   
(21.30
)%
   
14.78
%
   
11.28
%
   
9.50
%
Alger Small Cap Growth Institutional Class Z-2 (Inception 8/1/16)
   
(20.68
)%
   
15.70
%
   
n/a
     
16.52
%
 
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains.
 
Previously, the Alger Focus Equity Fund followed different investment strategies under the name "Alger Large Cap Growth Institutional Fund" and was managed by different portfolio managers. Performance prior to December 31, 2012 reflects those management styles and does not reflect the current investment personnel and strategies of the Fund. On October 15, 2018, Alger Capital Appreciation Focus Fund changed its name to Alger Focus Equity Fund.

*
Since inception performance is calculated from 11/8/93. Performance ftgures prior to 1/27/03, inception of  Class R shares, are those of the Fund's Class I shares. The performance ftgures prior to 1/27/03 have been reduced to reflect the higher operating expenses of Class R shares.

ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND

Fund Highlights Through April 30, 2022 (Unaudited)



The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Capital Appreciation Institutional Fund Class I shares and the Russell 1000 Growth Index (an unmanaged index of common stocks) for the ten years ended April 30, 2022. Figures for the Alger Capital Appreciation Institutional Fund Class I shares and the Russell 1000 Growth Index include reinvestment of dividends. Figures for the Alger Capital Appreciation Institutional Fund Class I shares also include reinvestment of capital gains. Performance for the Alger Capital Appreciation Institutional Fund Class R, Class Y and Class Z-2 shares may vary from the results shown above due to differences in expenses each class bears. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND

Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
11/8/1993
 
Class I (Inception 11/8/93)
   
(18.11
)%
   
13.56
%
   
13.60
%
   
12.16
%
Class R (Inception 1/27/03)*
   
(18.45
)%
   
13.06
%
   
13.07
%
   
11.61
%
Russell 1000 Growth Index
   
(5.35
)%
   
17.28
%
   
15.56
%
   
10.37
%


  1 YEAR     5 YEARS     10 YEARS    
Since
Inception
 
Class Y (Inception 2/28/17)
   
(17.80
)%
   
14.02
%
   
n/a
     
14.48
%
Russell 1000 Growth Index
   
(5.35
)%
   
17.28
%
   
n/a
     
17.45
%


 
1 YEAR
    5 YEARS    
10 YEARS
   
Since
Inception
 
Class Z-2 (Inception 10/14/16)
   
(17.85
)%
   
13.93
%
   
n/a
     
15.17
%
Russell 1000 Growth Index
   
(5.35
)%
   
17.28
%
   
n/a
     
18.35
%
 
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund's average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund's shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call  us at (800) 992-3863.
 
*
Performance ftgures prior to 1/27/03, inception of  Class R shares, are those of  the Fund's Class I shares. The performance ftgures prior to 1/27/03 have been reduced to reflect the higher operating expenses of Class R shares.

ALGER FOCUS EQUITY FUND

Fund Highlights Through April 30, 2022 (Unaudited)



The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Focus Equity Fund Class I shares and the Russell 1000 Growth Index (an unmanaged index of common stocks) for the ten years ended April 30, 2022. Previously, the Fund followed different investment strategies under the name "Alger Large Cap Growth Institutional Fund" and was managed by different portfolio managers. Performance prior to December 31, 2012 reflects those management styles and does not reflect the current investment personnel and strategies of the Fund. On October 15, 2018, Alger Capital Appreciation Focus Fund changed its name to Alger Focus Equity Fund. Figures for Alger Focus Equity Fund Class I shares and the Russell 1000 Growth Index include reinvestment of dividends. Figures for the Alger Focus Equity Fund Class I shares also include reinvestment of capital gains. Performance for Alger Focus Equity Fund Class A, Class C, Class Y and Class Z shares may vary from the results shown above due to differences in expenses and sales charges that those classes bear. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

ALGER FOCUS EQUITY FUND

Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS


  1 YEAR     5 YEARS    
10 YEARS
   
Since
Inception
 
Class I (Inception 11/8/93)
   
(17.34
)%
   
15.90
%
   
14.50
%
   
9.85
%
Russell 1000 Growth Index
   
(5.35
)%
   
17.28
%
   
15.56
%
   
10.37
%


  1 YEAR     5 YEARS    
10 YEARS
   
Since
Inception
 
Class A (Inception 12/31/12)
   
(21.71
)%
   
14.60
%
   
n/a
     
15.29
%
Class C (Inception 12/31/12)
   
(18.71
)%
   
14.97
%
   
n/a
     
15.09
%
Class Z (Inception 12/31/12)
   
(17.10
)%
   
16.23
%
   
n/a
     
16.36
%
Russell 1000 Growth Index
   
(5.35
)%
   
17.28
%
   
n/a
     
16.69
%


  1 YEAR     5 YEARS    
10 YEARS
   
Since
Inception
 
Class Y (Inception 2/28/17)
   
(17.08
)%
   
16.27
%
   
n/a
     
16.78
%
Russell 1000 Growth Index
   
(5.35
)%
   
17.28
%
   
n/a
     
17.45
%
 
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund's average annual total returns include changes in share price and reinvestment of dividends and capital gains. Class A returns reflect the maximum initial sales charge and Class C returns reflect the applicable contingent deferred sales charge. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Previously, the Fund followed different investment strategies under the name "Alger Large Cap Growth Institutional Fund" and was managed by different portfolio managers. Performance prior to December 31, 2012 reflects those management styles and does not reflect the current investment personnel and strategies of the Fund. On October 15, 2018, the Fund changed its name from Alger Capital Appreciation Focus Fund to Alger Focus Equity Fund. Investment return and principal will fluctuate and the Fund's shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.

ALGER MID CAP GROWTH INSTITUTIONAL FUND

Fund Highlights Through April 30, 2022 (Unaudited)



The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Mid Cap Growth Institutional Fund Class I shares and the Russell Midcap Growth Index (an unmanaged index of common stocks) for the ten years ended April 30, 2022. Figures for Alger Mid Cap Growth Institutional Fund Class I shares and the Russell Midcap Growth Index include reinvestment of dividends. Figures for the Alger Mid Cap Growth Institutional Fund Class I shares also include reinvestment of capital gains. Performance for the Alger Mid Cap Growth Institutional Fund Class R and Class Z-2 shares may vary from the results shown above due to differences in expenses the class bears. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

- 16 -

ALGER MID CAP GROWTH INSTITUTIONAL FUND

Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

    1 YEAR     5 YEARS     10 YEARS    
Since
11/8/1993
 
Class I (Inception 11/8/93)
   
(29.09
)%
   
11.42
%
   
11.26
%
   
11.55
%
Class R (Inception 1/27/03)*
   
(29.42
)%
   
10.89
%
   
10.70
%
   
10.99
%
Russell Midcap Growth Index
   
(16.73
)%
   
12.06
%
   
12.17
%
   
9.86
%

    1 YEAR     5 YEARS     10 YEARS    
Since
Inception
 
Class Z-2 (Inception 10/14/16)
   
(28.82
)%
   
11.77
%
   
n/a
     
13.57
%
Russell Midcap Growth Index
   
(16.73
)%
   
12.06
%
   
n/a
     
13.18
%
 
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund's average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund's shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call  us at (800) 992-3863.
 
*
Performance ftgures prior to 1/27/03, inception of  Class R shares, are those of  the Fund's Class I shares. The performance ftgures prior to 1/27/03 have been reduced to reflect the higher operating expenses of Class R shares.

ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Fund Highlights Through April 30, 2022 (Unaudited)


The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Small Cap Growth Institutional Fund Class I shares and the Russell 2000 Growth Index (an unmanaged index of common stocks) for the ten years ended April 30, 2022. Figures for the Alger Small Cap Growth Institutional Fund Class I shares and the Russell 2000 Growth Index include reinvestment of dividends. Figures for the Alger Small Cap Growth Institutional Fund Class I shares also include reinvestment of capital gains. Performance for the Alger Small Cap Growth Institutional Fund Class R and Class Z-2 shares may vary from the results shown above due to differences in expenses the class bears. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

- 18 -

ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Fund Highlights Through April 30, 2022 (Unaudited) (Continued)

PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS
 
   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
11/8/1993
 
Class I (Inception 11/8/93)
   
(34.53
)%
   
11.75
%
   
10.28
%
   
9.45
%
Class R (Inception 1/27/03)*
   
(34.81
)%
   
11.24
%
   
9.75
%
   
8.92
%
Russell 2000 Growth Index
   
(26.44
)%
   
7.08
%
   
9.95
%
   
7.27
%

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
Inception
 
Class Z-2 (Inception 8/1/16)
   
(34.34
)%
   
12.12
%
   
n/a
     
13.40
%
Russell 2000 Growth Index
   
(26.44
)%
   
7.08
%
   
n/a
     
8.53
%

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund's average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund's shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call  us at (800) 992-3863.
 
* Performance ftgures prior to 1/27/03, inception of  Class R shares, are those of  the Fund's Class I shares. The performance ftgures prior to 1/27/03 have been reduced to reflect the higher operating expenses of Class R shares.

- 19 -

PORTFOLIO SUMMARY

April 30, 2022 (Unaudited)


 
 
SECTORS
 
Alger Capital
Appreciation
Institutional Fund
   
Alger Focus Equity
Fund
   
Alger Mid Cap Growth
Institutional Fund
   
Alger Small Cap
Growth Institutional
Fund
 
Communication Services
   
7.3
%
   
7.7
%
   
4.9
%
   
5.7
%
Consumer Discretionary
   
19.7
     
19.9
     
13.9
     
11.8
 
Consumer Staples
   
0.4
     
0.0
     
0.5
     
5.3
 
Energy
   
2.4
     
2.2
     
8.1
     
5.9
 
Financials
   
3.1
     
4.7
     
4.3
     
1.1
 
Healthcare
   
14.8
     
11.6
     
16.7
     
29.7
 
Industrials
   
8.2
     
7.1
     
11.5
     
6.0
 
Information Technology
   
42.3
     
41.2
     
30.1
     
30.4
 
Materials
   
1.0
     
0.3
     
1.6
     
2.5
 
Real Estate
   
0.4
     
0.0
     
0.5
     
1.0
 
Utilities
   
0.3
     
0.0
     
2.6
     
0.0
 
Short-Term Investments and Net Other Assets
   
0.1
     
5.3
     
5.3
     
0.6
 
     
100.0
%
   
100.0
%
   
100.0
%
   
100.0
%
 
Based on net assets for each Fund.

THE ALGER INSTITUTIONAL FUNDS
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited)

COMMON STOCKS—99.3%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—3.3%
           
HEICO Corp.
   
111,366
   
$
15,728,220
 
Lockheed Martin Corp.
   
44,249
     
19,120,878
 
Raytheon Technologies Corp.
   
79,528
     
7,548,003
 
TransDigm Group, Inc.*
   
82,036
     
48,795,833
 
             
91,192,934
 
AGRICULTURAL & FARM MACHINERY—0.5%
               
Deere & Co.
   
35,620
     
13,448,331
 
AIR FREIGHT & LOGISTICS—0.2%
               
GXO Logistics, Inc.*
   
77,772
     
4,603,325
 
ALUMINUM—0.1%
               
Alcoa Corp.
   
42,618
     
2,889,500
 
APPAREL ACCESSORIES & LUXURY GOODS—1.7%
               
Capri Holdings Ltd.*
   
324,684
     
15,487,427
 
Lululemon Athletica, Inc.*
   
20,354
     
7,218,139
 
LVMH Moet Hennessy Louis Vuitton SE
   
36,892
     
23,870,720
 
             
46,576,286
 
APPLICATION SOFTWARE—8.5%
               
Adobe, Inc.*
   
85,585
     
33,887,381
 
Atlassian Corp., PLC, Cl. A*
   
66,889
     
15,038,654
 
Avalara, Inc.*
   
100,109
     
7,615,292
 
Bill.com Holdings, Inc.*
   
58,797
     
10,037,236
 
Cadence Design Systems, Inc.*
   
152,306
     
22,975,360
 
Confuent, Inc , C A*
   
125,337
     
3,915,528
 
Datadog, Inc., Cl. A*
   
175,390
     
21,183,604
 
Intuit, Inc.
   
196,343
     
82,218,631
 
Salesforce, Inc.*
   
113,022
     
19,885,091
 
Unity Software, Inc.*
   
162,585
     
10,797,270
 
Zendesk, Inc.*
   
58,263
     
7,110,416
 
             
234,664,463
 
AUTOMOBILE MANUFACTURERS—3.4%
               
General Motors Co.*
   
231,073
     
8,759,978
 
Tesla, Inc.*
   
96,611
     
84,124,994
 
             
92,884,972
 
BIOTECHNOLOGY—3.3%
               
AbbVie, Inc.
   
269,467
     
39,579,313
 
Horizon Therapeutics PLC*
   
133,973
     
13,204,379
 
Natera, Inc.*
   
324,110
     
11,382,743
 
Vertex Pharmaceuticals, Inc.*
   
96,331
     
26,319,556
 
             
90,485,991
 
CASINOS & GAMING—2.5%
               
MGM Resorts International
   
1,714,315
     
70,355,488
 
CONSUMER FINANCE—0.4%
               
Upstart Holdings, Inc.*
   
155,886
     
11,694,568
 
COPPER—0.4%
               
Freeport-McMoRan, Inc.
   
265,839
     
10,779,772
 

THE ALGER INSTITUTIONAL FUNDS
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—99.3% (CONT.)
 
SHARES
   
VALUE
 
DATA PROCESSING & OUTSOURCED SERVICES—4.6%
           
Block, Inc., Cl. A*
   
137,735
   
$
13,710,142
 
Marqeta, Inc., Cl. A*
   
1,548,074
     
14,397,088
 
PayPal Holdings, Inc.*
   
220,857
     
19,419,956
 
Visa, Inc., Cl. A
   
376,187
     
80,176,735
 
             
127,703,921
 
ELECTRIC UTILITIES—0.3%
               
NextEra Energy, Inc.
   
129,027
     
9,163,498
 
ELECTRICAL COMPONENTS & EQUIPMENT—2.8%
               
AMETEK, Inc.
   
154,529
     
19,510,832
 
Eaton Corp. PLC
   
309,569
     
44,893,696
 
Generac Holdings, Inc.*
   
60,748
     
13,326,896
 
             
77,731,424
 
FINANCIAL EXCHANGES & DATA—1.5%
               
S&P Global, Inc.
   
112,051
     
42,187,202
 
FOOTWEAR—0.7%
               
NIKE, Inc., Cl. B
   
154,029
     
19,207,416
 
HEALTHCARE DISTRIBUTORS—0.9%
               
McKesson Corp.
   
83,422
     
25,828,285
 
HEALTHCARE EQUIPMENT—2.7%
               
Dexcom, Inc.*
   
10,441
     
4,265,984
 
Edwards Lifesciences Corp.*
   
242,623
     
25,664,661
 
Intuitive Surgical, Inc.*
   
187,135
     
44,781,405
 
             
74,712,050
 
HEALTHCARE FACILITIES—0.7%
               
Acadia Healthcare Co., Inc.*
   
241,935
     
16,422,548
 
Tenet Healthcare Corp.*
   
41,235
     
2,989,950
 
             
19,412,498
 
HOTELS RESORTS & CRUISE LINES—1.4%
               
Airbnb, Inc., Cl. A*
   
103,819
     
15,906,109
 
Expedia Group, Inc.*
   
49,885
     
8,717,404
 
Hilton Worldwide Holdings, Inc.*
   
96,715
     
15,018,872
 
             
39,642,385
 
HYPERMARKETS & SUPER CENTERS—0.4%
               
Costco Wholesale Corp.
   
20,924
     
11,125,709
 
INTERACTIVE MEDIA & SERVICES—5.8%
               
Alphabet, Inc., Cl. C*
   
57,637
     
132,526,483
 
Meta Platforms, Inc., Cl. A*
   
39,501
     
7,918,766
 
Snap, Inc., Cl. A*
   
678,807
     
19,318,847
 
             
159,764,096
 
INTERNET & DIRECT MARKETING RETAIL—7.9%
               
Alibaba Group Holding Ltd.#,*
   
288,628
     
28,022,893
 
Altaba, Inc.*,(a)
   
342,659
     
1,202,733
 
Amazon.com, Inc.*
   
71,980
     
178,915,647
 
MercadoLibre, Inc.*
   
11,927
     
11,612,485
 
             
219,753,758
 

THE ALGER INSTITUTIONAL FUNDS
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—99.3% (CONT.)
 
SHARES
   
VALUE
 
INTERNET SERVICES & INFRASTRUCTURE—2.4%
           
MongoDB, Inc., Cl. A*
   
70,131
   
$
24,891,596
 
Shopify, Inc., Cl. A*
   
47,675
     
20,348,643
 
Snowflake, Inc., Cl. A*
   
128,390
     
22,011,182
 
             
67,251,421
 
INVESTMENT BANKING & BROKERAGE—0.0%
               
Morgan Stanley
   
17,239
     
1,389,291
 
LEISURE FACILITIES—1.2%
               
Vail Resorts, Inc.
   
132,484
     
33,672,133
 
LIFE SCIENCES TOOLS & SERVICES—1.9%
               
Danaher Corp.
   
206,770
     
51,926,150
 
MANAGED HEALTHCARE—3.0%
               
UnitedHealth Group, Inc.
   
161,479
     
82,120,145
 
MOVIES & ENTERTAINMENT—1.5%
               
Live Nation Entertainment, Inc.*
   
389,747
     
40,876,665
 
OIL & GAS EXPLORATION & PRODUCTION—1.7%
               
Pioneer Natural Resources Co.
   
206,051
     
47,900,676
 
OIL & GAS STORAGE & TRANSPORTATION—0.7%
               
Cheniere Energy, Inc.
   
147,421
     
20,021,246
 
PHARMACEUTICALS—2.3%
               
AstraZeneca PLC#
   
307,048
     
20,387,987
 
Bayer AG*
   
636,798
     
41,940,584
 
             
62,328,571
 
REGIONAL BANKS—1.2%
               
Signature Bank
   
131,384
     
31,827,774
 
RESTAURANTS—0.9%
               
Chipotle Mexican Grill, Inc., Cl. A*
   
3,967
     
5,774,405
 
Shake Shack, Inc., Cl. A*
   
256,688
     
14,844,267
 
Yum China Holdings, Inc.
   
102,685
     
4,292,233
 
             
24,910,905
 
SEMICONDUCTOR EQUIPMENT—2.1%
               
Applied Materials, Inc.
   
196,391
     
21,671,747
 
ASML Holding NV#
   
12,160
     
6,855,443
 
Enphase Energy, Inc.*
   
32,695
     
5,276,973
 
Lam Research Corp.
   
30,840
     
14,364,038
 
SolarEdge Technologies, Inc.*
   
34,243
     
8,574,790
 
             
56,742,991
 
SEMICONDUCTORS—4.8%
               
Advanced Micro Devices, Inc.*
   
725,778
     
62,068,535
 
NVIDIA Corp.
   
262,324
     
48,653,232
 
QUALCOMM, Inc.
   
153,044
     
21,378,716
 
             
132,100,483
 
SPECIALTY CHEMICALS—0.5%
               
Albemarle Corp.
   
75,109
     
14,483,269
 
SYSTEMS SOFTWARE—13.5%
               
Crowdstrike Holdings, Inc., Cl. A*
   
133,596
     
26,553,541
 
Microsoft Corp.
   
1,228,508
     
340,935,540
 
Palo Alto Networks, Inc.*
   
12,300
     
6,903,744
 
             
374,392,825
 

- 23 -

THE ALGER INSTITUTIONAL FUNDS
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—99.3% (CONT.)
 
SHARES
   
VALUE
 
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—6.2%
   




 
Apple, Inc.     1,088,599     $ 171,617,632  
TRUCKING—1.4%
   




 
Uber Technologies, Inc.*     781,032       24,586,887  
XPO Logistics, Inc.*
   
268,812
     
14,459,398
 
             
39,046,285
 
TOTAL COMMON STOCKS
            

 
(Cost $2,041,874,296)
            2,748,416,334  
PREFERRED STOCKS—0.1%
 
SHARES
   
VALUE
 
DATA PROCESSING & OUTSOURCED SERVICES—0.1%
   




 
Chime Financial, Inc., Series G*,@,(a)     38,919       2,315,291  
(Cost $2,688,128)
           
2,315,291
 
REAL ESTATE INVESTMENT TRUST—0.4%
 
SHARES
   
VALUE
 
SPECIALIZED—0.4%
   




 
Crown Castle International Corp.     53,065       9,828,169  
(Cost $9,624,851)
           
9,828,169
 
SPECIAL PURPOSE VEHICLE—0.1%
 
SHARES
   
VALUE
 
DATA PROCESSING & OUTSOURCED SERVICES—0.1%
   




 
Crosslink Ventures Capital LLC, Cl. A*,@,(a),(b)     123       4,293,561  
(Cost $3,075,000)
           
4,293,561
 
Total Investments
   




 
(Cost $2,057,262,275)
    99.9 %   $ 2,764,853,355  
Affiliated Securities (Cost $3,075,000)
           
4,293,561
 
Unaffiliated Securities (Cost $2,054,187,275)
           
2,760,559,794
 
Other Assets in Excess of Liabilities
   
0.1
%
   
1,864,059
 
NET ASSETS
   
100.0
%
 
$
2,766,717,414
 

#
American Depositary Receipts.
(a)
Security is valued in good faith at fair value determined using signiftcant unobservable inputs pursuant to procedures established  by the Board.
(b)
Deemed an afftliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 11 - Afftliated Securities.
*
Non-income producing security.
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualifted buyers.

Security

Acquisition
Date(s)

Acquisition
Cost


% of net assets
(Acquisition
Date)


Market
Value


% of net assets
as of
4/30/2022
 
Chime Financial, Inc., Series G
 
8/24/21
   
2,688,128
     
0.06
%
   
2,315,291
     
0.08
%
Crosslink Ventures Capital LLC, Cl. A
 
10/2/20
   
3,075,000
     
0.08
%
   
4,293,561
     
0.15
%
Total
                       
6,608,852
     
0.23
%

See Notes to Financial Statements.

- 24 -

THE ALGER INSTITUTIONAL FUNDS  
  ALGER FOCUS EQUITY FUND
Schedule of Investments April 30, 2022 (Unaudited)

COMMON STOCKS—94.7%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—2.0%
           
Textron, Inc.
   
37,825
   
$
2,619,381
 
TransDigm Group, Inc.*
   
35,468
     
21,096,721
 
             
23,716,102
 
APPAREL ACCESSORIES & LUXURY GOODS—0.6%
               
Capri Holdings Ltd.*
   
152,397
     
7,269,337
 
APPLICATION SOFTWARE—6.8%
               
Adobe, Inc.*
   
34,081
     
13,494,372
 
Bill.com Holdings, Inc.*
   
30,445
     
5,197,266
 
Intuit, Inc.
   
117,949
     
49,391,144
 
Salesforce, Inc.*
   
49,162
     
8,649,562
 
Unity Software, Inc.*
   
70,169
     
4,659,923
 
             
81,392,267
 
AUTOMOBILE MANUFACTURERS—4.0%
               
General Motors Co.*
   
319,443
     
12,110,084
 
Tesla, Inc.*
   
41,439
     
36,083,424
 
             
48,193,508
 
CASINOS & GAMING—3.8%
               
MGM Resorts International
   
1,101,947
     
45,223,905
 
CONSUMER FINANCE—0.5%
               
Upstart Holdings, Inc.*
   
75,957
     
5,698,294
 
COPPER—0.3%
               
Freeport-McMoRan, Inc.
   
92,050
     
3,732,627
 
DATA PROCESSING & OUTSOURCED SERVICES—5.1%
               
Marqeta, Inc., Cl. A*
   
656,572
     
6,106,120
 
PayPal Holdings, Inc.*
   
65,897
     
5,794,323
 
Visa, Inc., Cl. A
   
227,983
     
48,590,017
 
             
60,490,460
 
ELECTRICAL COMPONENTS & EQUIPMENT—3.5%
               
AMETEK, Inc.
   
97,954
     
12,367,672
 
Eaton Corp. PLC
   
207,664
     
30,115,433
 
             
42,483,105
 
FINANCIAL EXCHANGES & DATA—2.2%
               
S&P Global, Inc.
   
70,097
     
26,391,521
 
FOOTWEAR—0.8%
               
NIKE, Inc., Cl. B
   
78,026
     
9,729,842
 
HEALTHCARE DISTRIBUTORS—1.5%
               
McKesson Corp.
   
58,649
     
18,158,317
 
HEALTHCARE EQUIPMENT—1.1%
               
Edwards Lifesciences Corp.*
   
120,711
     
12,768,810
 
HOTELS RESORTS & CRUISE LINES—1.7%
               
Airbnb, Inc., Cl. A*
   
79,109
     
12,120,290
 
Booking Holdings, Inc.*
   
3,650
     
8,067,631
 
             
20,187,921
 
INTERACTIVE MEDIA & SERVICES—5.7%
               
Alphabet, Inc., Cl. C*
   
24,746
     
56,899,220
 
Snap, Inc., Cl. A*
   
391,191
     
11,133,296
 
             
68,032,516
 

- 25 -

THE ALGER INSTITUTIONAL FUNDS  
  ALGER FOCUS EQUITY FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—94.7% (CONT.)
 
SHARES
   
VALUE
 
INTERNET & DIRECT MARKETING RETAIL—8.5%
           
Alibaba Group Holding Ltd.#,*
   
169,757
   
$
16,481,707
 
Amazon.com, Inc.*
   
31,796
     
79,033,091
 
MercadoLibre, Inc.*
   
6,323
     
6,156,263
 
             
101,671,061
 
INTERNET SERVICES & INFRASTRUCTURE—2.2%
               
Shopify, Inc., Cl. A*
   
21,157
     
9,030,231
 
Snowflake, Inc., Cl. A*
   
80,491
     
13,799,377
 
Twilio, Inc., Cl. A*
   
26,684
     
2,983,805
 
             
25,813,413
 
LEISURE FACILITIES—0.5%
               
Vail Resorts, Inc.
   
25,343
     
6,441,177
 
LIFE SCIENCES TOOLS & SERVICES—2.1%
               
Danaher Corp.
   
98,041
     
24,621,036
 
MANAGED HEALTHCARE—4.7%
               
UnitedHealth Group, Inc.
   
111,557
     
56,732,312
 
MOVIES & ENTERTAINMENT—2.0%
               
Live Nation Entertainment, Inc.*
   
228,095
     
23,922,604
 
OIL & GAS EXPLORATION & PRODUCTION—2.2%
               
Pioneer Natural Resources Co.
   
115,177
     
26,775,197
 
PHARMACEUTICALS—2.2%
               
Bayer AG*
   
351,368
     
23,141,685
 
Catalent, Inc.*
   
35,156
     
3,183,728
 
             
26,325,413
 
REGIONAL BANKS—2.0%
               
Signature Bank
   
99,712
     
24,155,232
 
SEMICONDUCTOR EQUIPMENT—1.9%
               
Applied Materials, Inc.
   
136,243
     
15,034,415
 
SolarEdge Technologies, Inc.*
   
33,192
     
8,311,609
 
             
23,346,024
 
SEMICONDUCTORS—5.7%
               
Advanced Micro Devices, Inc.*
   
395,137
     
33,792,116
 
NVIDIA Corp.
   
115,601
     
21,440,518
 
QUALCOMM, Inc.
   
96,190
     
13,436,781
 
             
68,669,415
 
SYSTEMS SOFTWARE—13.4%
               
Crowdstrike Holdings, Inc., Cl. A*
   
70,482
     
14,009,002
 
Microsoft Corp.
   
526,984
     
146,248,600
 
             
160,257,602
 
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—6.1%
               
Apple, Inc.
   
466,851
     
73,599,060
 
TRUCKING—1.6%
               
Uber Technologies, Inc.*
   
393,627
     
12,391,378
 
XPO Logistics, Inc.*
   
117,532
     
6,322,046
 
             
18,713,424
 
TOTAL COMMON STOCKS
               
(Cost $1,034,465,809)
           
1,134,511,502
 

THE ALGER INSTITUTIONAL FUNDS  
  ALGER FOCUS EQUITY FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

PREFERRED STOCKS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%
Prosetta Biosciences, Inc., Series D*,@,(a),(b)
   
76,825
   
$
 
(Cost $345,713)
           
 
Total Investments
               
(Cost $1,034,811,522)
   
94.7
%
 
$
1,134,511,502
 
Affiliated Securities (Cost $345,713)
           
 
Unaffiliated Securities (Cost $1,034,465,809)
           
1,134,511,502
 
Other Assets in Excess of Liabilities
   
5.3
%
   
63,364,333
 
NET ASSETS
   
100.0
%
 
$
1,197,875,835
 

#
American Depositary Receipts.
(a)
Deemed an afftliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 11 - Afftliated Securities.
(b)
Security is valued in good faith at fair value determined using signiftcant unobservable inputs pursuant to procedures established  by the Board.
*
Non-income producing security.
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualifted buyers.

Security
 
Acquisition
Date(s)

Acquisition
Cost


% of net assets
(Acquisition
Date)


Market
Value


% of net assets
as of
4/30/2022
 
Prosetta Biosciences, Inc., Series D   2/6/15   $ 345,713       0.80
%
  $ 0
      0.00
%
Total
                     
0       0.00
%

See Notes to Financial Statements.

THE ALGER INSTITUTIONAL FUNDS  
  ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited)

COMMON STOCKS—92.2%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—5.2%
           
Axon Enterprise, Inc.*
   
3,095
   
$
347,259
 
HEICO Corp.
   
12,896
     
1,821,302
 
TransDigm Group, Inc.*
   
2,462
     
1,464,422
 
             
3,632,983
 
AIR FREIGHT & LOGISTICS—0.4%
               
GXO Logistics, Inc.*
   
4,573
     
270,676
 
APPAREL ACCESSORIES & LUXURY GOODS—2.8%
               
Lululemon Athletica, Inc.*
   
4,009
     
1,421,712
 
Moncler SpA
   
10,927
     
569,147
 
             
1,990,859
 
APPAREL RETAIL—2.2%
               
Aritzia, Inc.*
   
29,284
     
1,042,926
 
Burlington Stores, Inc.*
   
2,589
     
527,017
 
             
1,569,943
 
APPLICATION SOFTWARE—10.9%
               
Avalara, Inc.*
   
4,159
     
316,375
 
Bill.com Holdings, Inc.*
   
4,747
     
810,360
 
Cadence Design Systems, Inc.*
   
7,360
     
1,110,256
 
Datadog, Inc., Cl. A*
   
6,053
     
731,081
 
Manhattan Associates, Inc.*
   
8,652
     
1,129,519
 
Paycom Software, Inc.*
   
4,373
     
1,230,868
 
Sprout Social, Inc., Cl. A*
   
13,529
     
829,057
 
Synopsys, Inc.*
   
3,281
     
940,958
 
The Trade Desk, Inc., Cl. A*
   
10,080
     
593,914
 
             
7,692,388
 
AUTOMOTIVE RETAIL—1.3%
               
O'Reilly Automotive, Inc.*
   
1,507
     
914,071
 
BIOTECHNOLOGY—3.6%
               
Alkermes PLC*
   
9,438
     
272,286
 
Apellis Pharmaceuticals, Inc.*
   
6,996
     
304,536
 
BioMarin Pharmaceutical, Inc.*
   
5,065
     
412,038
 
BioNTech SE#,*
   
1,705
     
236,620
 
Celldex Therapeutics, Inc.*
   
11,173
     
341,335
 
Natera, Inc.*
   
19,531
     
685,929
 
Prometheus Biosciences, Inc.*
   
10,778
     
283,461
 
             
2,536,205
 
BUILDING PRODUCTS—0.7%
               
Trex Co., Inc.*
   
9,089
     
528,889
 
CASINOS & GAMING—2.0%
               
MGM Resorts International
   
33,472
     
1,373,691
 
CONSUMER FINANCE—1.4%
               
Upstart Holdings, Inc.*
   
12,812
     
961,156
 
DATA PROCESSING & OUTSOURCED SERVICES—1.4%
               
Marqeta, Inc., Cl. A*
   
108,492
     
1,008,976
 
DIVERSIFIED METALS & MINING—1.6%
               
MP Materials Corp.*
   
29,209
     
1,111,110
 
ELECTRIC UTILITIES—1.9%
               
NextEra Energy, Inc.
   
19,239
     
1,366,354
 

THE ALGER INSTITUTIONAL FUNDS  
  ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—92.2% (CONT.)
 
SHARES
   
VALUE
 
ELECTRICAL COMPONENTS & EQUIPMENT—2.3%
           
AMETEK, Inc.
   
6,370
   
$
804,276
 
Generac Holdings, Inc.*
   
3,709
     
813,681
 
             
1,617,957
 
ELECTRONIC EQUIPMENT & INSTRUMENTS—1.6%
               
908 Devices, Inc.*
   
41,877
     
743,317
 
Trimble, Inc.*
   
6,077
     
405,336
 
             
1,148,653
 
FINANCIAL EXCHANGES & DATA—0.7%
               
MSCI, Inc., Cl. A
   
1,204
     
507,185
 
HEALTHCARE DISTRIBUTORS—2.2%
               
AmerisourceBergen Corp., Cl. A
   
4,953
     
749,339
 
McKesson Corp.
   
2,520
     
780,217
 
             
1,529,556
 
HEALTHCARE EQUIPMENT—2.2%
               
Dexcom, Inc.*
   
1,735
     
708,886
 
Insulet Corp.*
   
3,493
     
834,792
 
             
1,543,678
 
HEALTHCARE SERVICES—0.3%
               
Guardant Health, Inc.*
   
3,358
     
207,189
 
HEALTHCARE TECHNOLOGY—0.7%
               
Veeva Systems, Inc., Cl. A*
   
2,859
     
520,195
 
HOTELS RESORTS & CRUISE LINES—1.0%
               
Airbnb, Inc., Cl. A*
   
2,294
     
351,464
 
Expedia Group, Inc.*
   
2,056
     
359,286
 
             
710,750
 
HYPERMARKETS & SUPER CENTERS—0.5%
               
BJ's Wholesale Club Holdings, Inc.*
   
5,342
     
343,758
 
INTERACTIVE HOME ENTERTAINMENT—1.9%
               
Take-Two Interactive Software, Inc.*
   
10,922
     
1,305,288
 
INTERACTIVE MEDIA & SERVICES—0.3%
               
Snap, Inc., Cl. A*
   
6,359
     
180,977
 
INTERNET SERVICES & INFRASTRUCTURE—1.2%
               
MongoDB, Inc., Cl. A*
   
2,293
     
813,854
 
LEISURE FACILITIES—1.1%
               
Vail Resorts, Inc.
   
2,930
     
744,689
 
LIFE SCIENCES TOOLS & SERVICES—4.2%
               
10X Genomics, Inc., Cl. A*
   
3,854
     
184,067
 
Azenta, Inc.
   
7,567
     
567,222
 
Bio-Techne Corp.
   
4,142
     
1,572,676
 
Repligen Corp.*
   
2,275
     
357,721
 
West Pharmaceutical Services, Inc.
   
956
     
301,198
 
             
2,982,884
 
MOVIES & ENTERTAINMENT—2.7%
               
Liberty Media Corp.-Liberty Formula One, Cl. C*
   
11,629
     
724,836
 
Live Nation Entertainment, Inc.*
   
11,065
     
1,160,497
 
             
1,885,333
 

- 29 -

Table of Contents
THE ALGER INSTITUTIONAL FUNDS  
  ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—92.2% (CONT.)
 
SHARES
   
VALUE
 
OIL & GAS EQUIPMENT & SERVICES—4.0%
           
Baker Hughes Co., Cl. A
   
42,494
   
$
1,318,164
 
ChampionX Corp.
   
52,472
     
1,107,159
 
ProPetro Holding Corp.*
   
29,573
     
418,162
 
             
2,843,485
 
OIL & GAS EXPLORATION & PRODUCTION—4.1%
               
Diamondback Energy, Inc.
   
12,280
     
1,550,105
 
Pioneer Natural Resources Co.
   
5,805
     
1,349,488
 
             
2,899,593
 
PHARMACEUTICALS—3.1%
               
Catalent, Inc.*
   
14,318
     
1,296,638
 
Green Thumb Industries, Inc.*
   
24,239
     
339,829
 
Jazz Pharmaceuticals PLC*
   
1,693
     
271,252
 
Pacira BioSciences, Inc.*
   
3,445
     
256,894
 
             
2,164,613
 
REGIONAL BANKS—2.2%
               
Signature Bank
   
6,462
     
1,565,419
 
RENEWABLE ELECTRICITY—0.7%
               
NextEra Energy Partners LP
   
7,142
     
476,086
 
RESEARCH & CONSULTING SERVICES—0.6%
               
CoStar Group, Inc.*
   
6,180
     
393,172
 
RESTAURANTS—3.5%
               
Chipotle Mexican Grill, Inc., Cl. A*
   
539
     
784,574
 
Shake Shack, Inc., Cl. A*
   
21,886
     
1,265,667
 
The Cheesecake Factory, Inc.*
   
11,225
     
414,315
 
             
2,464,556
 
SEMICONDUCTOR EQUIPMENT—5.0%
               
Applied Materials, Inc.
   
5,086
     
561,240
 
Enphase Energy, Inc.*
   
2,332
     
376,385
 
KLA Corp.
   
2,356
     
752,176
 
Lam Research Corp.
   
798
     
371,676
 
Onto Innovation, Inc.*
   
2,769
     
196,987
 
SolarEdge Technologies, Inc.*
   
5,100
     
1,277,091
 
             
3,535,555
 
SEMICONDUCTORS—3.4%
               
Advanced Micro Devices, Inc.*
   
11,908
     
1,018,372
 
Microchip Technology, Inc.
   
11,854
     
772,881
 
SiTime Corp.*
   
3,686
     
621,349
 
             
2,412,602
 
SYSTEMS SOFTWARE—5.0%
               
Crowdstrike Holdings, Inc., Cl. A*
   
5,969
     
1,186,398
 
Fortinet, Inc.*
   
2,947
     
851,713
 
Palo Alto Networks, Inc.*
   
2,615
     
1,467,747
 
             
3,505,858
 
TRUCKING—2.3%
               
Old Dominion Freight Line, Inc.
   
4,468
     
1,251,576
 

- 30 -

Table of Contents
THE ALGER INSTITUTIONAL FUNDS  
  ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)


COMMON STOCKS—92.2% (CONT.)
 
SHARES
   
VALUE
 
TRUCKING—2.3% (CONT.)
           
Uber Technologies, Inc.*
    11,977
    $ 377,036  
             
1,628,612
 
TOTAL COMMON STOCKS
               
(Cost $71,464,617)
           
64,888,798
 
PREFERRED STOCKS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%
   

     
 
Prosetta Biosciences, Inc., Series D*,@,(a),(b)
   
166,009
     
 
(Cost $747,040)
           
 
RIGHTS—0.4%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.4%
           
Tolero CDR*,@,(b),(c)
   
422,928
     
304,508
 
(Cost $226,186)
           
304,508
 
REAL ESTATE INVESTMENT TRUST—0.5%
 
SHARES
   
VALUE
 
SPECIALIZED—0.5%
           
Crown Castle International Corp.
   
2,003
     
370,976
 
(Cost $396,604)
           
370,976
 
SPECIAL PURPOSE VEHICLE—1.6%
 
SHARES
   
VALUE
 
DATA PROCESSING & OUTSOURCED SERVICES—1.6%
           
Crosslink Ventures Capital LLC, Cl. A*,@,(a),(b)
   
22
     
767,954
 
Crosslink Ventures Capital LLC, Cl. B*,@,(a),(b)
   
9
     
326,925
 
             
1,094,879
 
TOTAL SPECIAL PURPOSE VEHICLE
               
(Cost $775,000)
           
1,094,879
 
Total Investments
               
(Cost $73,609,447)
   
94.7
%
 
$
66,659,161
 
Affiliated Securities (Cost $1,522,040)
           
1,094,879
 
Unaffiliated Securities (Cost $72,087,407)
           
65,564,282
 
Other Assets in Excess of Liabilities
   
5.3
%
   
3,740,845
 
NET ASSETS
   
100.0
%
 
$
70,400,006
 

#
American Depositary Receipts.
(a)
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 11 - Affiliated Securities.
(b)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established  by the Board.
(c)
Contingent Deferred Rights.
*
Non-income producing security.
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

Security
Acquisition
Date(s)
 
Acquisition
Cost
   
% of net assets
(Acquisition
Date)
   
Market
Value
   
% of net assets
as of
4/30/2022
 
Crosslink Ventures Capital LLC, Cl. A
10/2/20
 
$
550,000
     
0.50
%
 
$
767,954
     
1.09
%
Crosslink Ventures Capital LLC, Cl. B
12/16/20
   
225,000
     
0.19
%
   
326,925
     
0.47
%
Prosetta Biosciences, Inc., Series D
2/6/15
   
747,040
     
0.50
%
    0
     
0.00
%
Tolero CDR
2/6/17
   
226,186
     
0.23
%
   
304,508
     
0.43
%

Total
                   
1,399,387
     
1.99
%

See Notes to Financial Statements.

- 31 -

Table of Contents
THE ALGER INSTITUTIONAL FUNDS  
  ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—93.7%
 
SHARES
   
VALUE
 
ADVERTISING—0.4%
           
Magnite, Inc.*
   
81,700
   
$
788,405
 
AEROSPACE & DEFENSE—3.3%
               
HEICO Corp.
   
25,263
     
3,567,893
 
Hexcel Corp.
   
12,486
     
678,739
 
Mercury Systems, Inc.*
   
43,625
     
2,433,839
 
             
6,680,471
 
AGRICULTURAL & FARM MACHINERY—0.2%
               
Hydrofarm Holdings Group, Inc.*
   
45,962
     
438,937
 
APPAREL ACCESSORIES & LUXURY GOODS—1.2%
               
Capri Holdings Ltd.*
   
50,413
     
2,404,700
 
APPAREL RETAIL—2.1%
               
Aritzia, Inc.*
   
50,073
     
1,783,310
 
Victoria's Secret & Co.*
   
54,535
     
2,569,689
 
             
4,352,999
 
APPLICATION SOFTWARE—20.9%
               
ACI Worldwide, Inc.*
   
104,482
     
2,885,793
 
Avalara, Inc.*
   
36,322
     
2,763,015
 
Bill.com Holdings, Inc.*
   
22,027
     
3,760,229
 
Blackbaud, Inc.*
   
34,609
     
2,007,668
 
Blackline, Inc.*
   
34,208
     
2,293,646
 
Digital Turbine, Inc.*
   
25,706
     
813,595
 
Everbridge, Inc.*
   
42,785
     
1,844,033
 
ForgeRock, Inc., Cl. A*
   
14,085
     
287,757
 
Guidewire Software, Inc.*
   
19,478
     
1,693,417
 
HubSpot, Inc.*
   
7,818
     
2,966,384
 
Manhattan Associates, Inc.*
   
31,095
     
4,059,452
 
Paycom Software, Inc.*
   
11,823
     
3,327,820
 
Paycor HCM, Inc.*
   
4,766
     
117,387
 
Q2 Holdings, Inc.*
   
55,535
     
2,872,826
 
SEMrush Holdings, Inc., Cl. A*
   
47,723
     
465,776
 
Smartsheet, Inc., Cl. A*
   
36,524
     
1,765,205
 
Sprout Social, Inc., Cl. A*
   
44,365
     
2,718,687
 
SPS Commerce, Inc.*
   
35,187
     
4,209,421
 
Vertex, Inc., Cl. A*
   
94,237
     
1,340,992
 
             
42,193,103
 
ASSET MANAGEMENT & CUSTODY BANKS—0.3%
               
Affiliated Managers Group, Inc
   
5,109
     
641,537
 
BIOTECHNOLOGY—2.9%
               
Alkermes PLC*
   
18,970
     
547,284
 
CareDx, Inc.*
   
126,904
     
3,862,958
 
Celldex Therapeutics, Inc.*
   
15,204
     
464,482
 
Karuna Therapeutics, Inc.*
   
6,802
     
758,151
 
Turning Point Therapeutics, Inc.*
   
8,458
     
249,004
 
             
5,881,879
 
DATA PROCESSING & OUTSOURCED SERVICES—1.2%
               
DLocal Ltd., Cl. A*
   
80,976
     
1,835,726
 
Marqeta, Inc., Cl. A*
   
74,534
     
693,166
 
             
2,528,892
 

- 32 -

Table of Contents
THE ALGER INSTITUTIONAL FUNDS  
  ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—93.7% (CONT.)
 
SHARES
   
VALUE
 
DIVERSIFIED SUPPORT SERVICES—0.4%
           
IAA, Inc.*
   
21,263
   
$
779,289
 
ELECTRICAL COMPONENTS & EQUIPMENT—0.4%
               
Sunrun, Inc.*
   
36,651
     
732,287
 
ELECTRONIC EQUIPMENT & INSTRUMENTS—1.8%
               
908 Devices, Inc.*
   
24,351
     
432,230
 
Cognex Corp.
   
47,829
     
3,234,676
 
             
3,666,906
 
FOOD DISTRIBUTORS—2.4%
               
The Chefs' Warehouse, Inc.*
   
45,752
     
1,674,523
 
US Foods Holding Corp.*
   
87,254
     
3,282,496
 
             
4,957,019
 
HEALTHCARE DISTRIBUTORS—0.3%
               
PetIQ, Inc., Cl. A*
   
29,488
     
586,811
 
HEALTHCARE EQUIPMENT—8.3%
               
CryoPort, Inc.*
   
58,749
     
1,325,377
 
Impulse Dynamics NV, Series E*,@,(a)
   
532,406
     
1,756,940
 
Inmode Ltd.*
   
85,260
     
2,140,879
 
Inogen, Inc.*
   
7,985
     
201,861
 
Insulet Corp.*
   
20,977
     
5,013,293
 
Mesa Laboratories, Inc.
   
10,892
     
2,326,858
 
Paragon 28, Inc.*
   
34,433
     
618,761
 
Tandem Diabetes Care, Inc.*
   
34,574
     
3,335,699
 
             
16,719,668
 
HEALTHCARE FACILITIES—1.2%
               
The Joint Corp.*
   
76,739
     
2,342,074
 
HEALTHCARE SERVICES—1.1%
               
Biodesix, Inc.*
   
34,078
     
54,866
 
Guardant Health, Inc.*
   
28,081
     
1,732,598
 
Privia Health Group, Inc.*
   
22,951
     
504,692
 
             
2,292,156
 
HEALTHCARE SUPPLIES—4.2%
               
Neogen Corp.*
   
179,100
     
4,728,240
 
Quidel Corp.*
   
36,948
     
3,717,708
 
             
8,445,948
 
HEALTHCARE TECHNOLOGY—2.0%
               
Convey Health Solutions Holdings, Inc.*
   
65,548
     
333,639
 
Definitive Healthcare Corp , Cl. A*
   
15,589
     
368,680
 
Doximity, Inc., Cl. A*
   
8,832
     
352,132
 
Renalytix PLC#,*
   
74,636
     
378,404
 
Sophia Genetics SA*
   
38,769
     
249,285
 
Veeva Systems, Inc., Cl. A*
   
13,137
     
2,390,277
 
             
4,072,417
 
HOMEBUILDING—0.3%
               
Skyline Champion Corp.*
   
11,072
     
565,115
 
HOMEFURNISHING RETAIL—0.8%
               
Arhaus, Inc., Cl. A*
   
23,071
     
165,419
 
Bed Bath & Beyond, Inc.*
   
100,265
     
1,364,607
 
             
1,530,026
 

- 33 -

Table of Contents
THE ALGER INSTITUTIONAL FUNDS  
  ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—93.7% (CONT.)
 
SHARES
   
VALUE
 
HUMAN RESOURCE & EMPLOYMENT SERVICES—1.2%
           
LegalZoom.com, Inc.*
   
69,733
   
$
1,000,669
 
Upwork, Inc.*
   
64,856
     
1,360,030
 
             
2,360,699
 
HYPERMARKETS & SUPER CENTERS—2.5%
               
BJ's Wholesale Club Holdings, Inc.*
   
79,417
     
5,110,484
 
INDUSTRIAL MACHINERY—0.5%
               
Gates Industrial Corp., PLC*
   
77,926
     
993,557
 
INTERACTIVE HOME ENTERTAINMENT—1.0%
               
Take-Two Interactive Software, Inc.*
   
16,608
     
1,984,822
 
INTERACTIVE MEDIA & SERVICES—1.9%
               
Bumble, Inc., Cl. A*
   
21,939
     
526,316
 
Eventbrite, Inc., Cl. A*
   
65,017
     
687,880
 
Genius Sports Ltd.*
   
285,006
     
1,088,723
 
Tripadvisor, Inc.*
   
60,697
     
1,558,092
 
             
3,861,011
 
INTERNET & DIRECT MARKETING RETAIL—0.7%
               
Farfetch Ltd., Cl. A*
   
65,054
     
728,605
 
The RealReal, Inc.*
   
129,405
     
701,375
 
             
1,429,980
 
INTERNET SERVICES & INFRASTRUCTURE—0.6%
               
BigCommerce Holdings, Inc.*
   
68,228
     
1,219,234
 
LEISURE FACILITIES—1.0%
               
Planet Fitness, Inc., Cl. A*
   
24,261
     
1,941,608
 
LIFE SCIENCES TOOLS & SERVICES—7.9%
               
Akoya Biosciences, Inc.*
   
66,342
     
624,278
 
Alpha Teknova, Inc.*
   
15,421
     
173,178
 
Bio-Techne Corp.
   
16,685
     
6,335,128
 
Codex DNA, Inc.*
   
38,575
     
142,727
 
Cytek Biosciences, Inc.*
   
27,150
     
256,567
 
ICON PLC*
   
8,908
     
2,015,079
 
Maravai LifeSciences Holdings, Inc., Cl. A*
   
21,044
     
646,682
 
MaxCyte, Inc.*
   
23,465
     
129,996
 
NanoString Technologies, Inc.*
   
102,524
     
1,925,401
 
NeoGenomics, Inc.*
   
71,563
     
676,270
 
Personalis, Inc.*
   
52,152
     
292,051
 
Rapid Micro Biosystems, Inc., Cl. A*
   
31,307
     
182,520
 
Repligen Corp.*
   
16,361
     
2,572,604
 
             
15,972,481
 
MANAGED HEALTHCARE—1.6%
               
HealthEquity, Inc.*
   
50,812
     
3,166,604
 
MOVIES & ENTERTAINMENT—2.4%
               
Live Nation Entertainment, Inc.*
   
45,775
     
4,800,882
 
OIL & GAS EQUIPMENT & SERVICES—0.9%
               
ChampionX Corp.
   
37,585
     
793,043
 
ProPetro Holding Corp.*
   
77,048
     
1,089,459
 
             
1,882,502
 

- 34 -

Table of Contents
THE ALGER INSTITUTIONAL FUNDS  
  ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—93.7% (CONT.)
 
SHARES
   
VALUE
 
OIL & GAS EXPLORATION & PRODUCTION—5.0%
           
Coterra Energy, Inc.
   
39,757
   
$
1,144,604
 
Magnolia Oil & Gas Corp., Cl. A
   
389,969
     
9,062,880
 
             
10,207,484
 
PERSONAL PRODUCTS—0.4%
               
The Beauty Health Co.*
   
55,593
     
728,268
 
PRECIOUS METALS & MINERALS—0.5%
               
Xometry, Inc., Cl. A*
   
30,049
     
986,208
 
REGIONAL BANKS—0.8%
               
Webster Financial Corp.
   
31,770
     
1,588,182
 
RESTAURANTS—4.8%
               
Shake Shack, Inc., Cl. A*
   
67,142
     
3,882,822
 
Sweetgreen, Inc., Cl. A*
   
18,023
     
486,621
 
The Cheesecake Factory, Inc.*
   
84,459
     
3,117,382
 
Wingstop, Inc.
   
23,609
     
2,166,362
 
             
9,653,187
 
SEMICONDUCTOR EQUIPMENT—0.6%
               
SolarEdge Technologies, Inc.*
   
5,080
     
1,272,083
 
SEMICONDUCTORS—0.8%
               
Universal Display Corp.
   
13,240
     
1,691,145
 
SPECIALTY CHEMICALS—2.0%
               
Balchem Corp.
   
32,965
     
4,061,288
 
SPECIALTY STORES—0.9%
               
Brilliant Earth Group, Inc., Cl. A*
   
10,779
     
82,998
 
Five Below, Inc.*
   
11,556
     
1,815,448
 
             
1,898,446
 
TOTAL COMMON STOCKS
               
(Cost $178,332,231)
           
189,410,794
 
PREFERRED STOCKS—3.4%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%
               
Prosetta Biosciences, Inc., Series D*,@,(a),(b)
   
133,263
     
 
DATA PROCESSING & OUTSOURCED SERVICES—3.4%
               
Chime Financial, Inc., Series G*,@,(a)
   
114,399
     
6,805,597
 
TOTAL PREFERRED STOCKS
               
(Cost $8,501,200)
           
6,805,597
 
RIGHTS—0.2%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.2%
               
Tolero CDR*,@,(a),(c)
   
528,559
     
380,562
 
(Cost $285,725)
           
380,562
 
REAL ESTATE INVESTMENT TRUST—1.0%
 
SHARES
   
VALUE
 
RETAIL—1.0%
               
Tanger Factory Outlet Centers, Inc.
   
125,834
     
2,029,702
 
(Cost $2,071,500)
           
2,029,702
 

- 35 -

Table of Contents
THE ALGER INSTITUTIONAL FUNDS  
  ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

SPECIAL PURPOSE VEHICLE—1.1%
 
SHARES
   
VALUE
 
DATA PROCESSING & OUTSOURCED SERVICES—1.1%
               
Crosslink Ventures Capital LLC, Cl. A*,@,(a),(b)
   
51
   
$
1,780,257
 
Crosslink Ventures Capital LLC, Cl. B*,@,(a),(b)
   
13
     
472,225
 
             
2,252,482
 
TOTAL SPECIAL PURPOSE VEHICLE
               
(Cost $1,600,000)
           
2,252,482
 
Total Investments
               
(Cost $190,790,656)
   
99.4
%
 
$
200,879,137
 
Affiliated Securities (Cost $2,199,684)
           
2,252,482
 
Unaffiliated Securities (Cost $188,590,972)
           
198,626,655
 
Other Assets in Excess of Liabilities
   
0.6
%
   
1,171,735
 
NET ASSETS
   
100.0
%
 
$
202,050,872
 

#
American Depositary Receipts.
(a)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established  by the Board.
(b)
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 11 - Affiliated Securities.
(c)
Contingent Deferred Rights.
*
Non-income producing security.
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.
 
Security
Acquisition
Date(s)

Acquisition
Cost


% of net assets
(Acquisition
Date)


Market
Value


% of net assets
as of
4/30/2022
 
Chime Financial, Inc., Series G
8/24/21
 
$
7,901,516
     
2.12
%
 
$
6,805,597
     
3.37
%
Crosslink Ventures Capital LLC, Cl. A
10/2/20
   
1,275,000
     
0.49
%
   
1,780,257
     
0.88
%
Crosslink Ventures Capital LLC, Cl. B
12/16/20
   
325,000
     
0.11
%
   
472,225
     
0.23
%
Impulse Dynamics NV, Series E
2/11/22
   
1,756,940
     
0.71
%
   
1,756,940
     
0.87
%
Prosetta Biosciences, Inc., Series D
2/6/15
   
599,684
     
0.10
%
   
0
     
0.00
%
Tolero CDR
2/6/17
   
285,725
     
0.16
%    
380,562
      0.19 %
Total
                     
11,195,581
      5.54 %

See Notes to Financial Statements.

- 36 -

Table of Contents
THE ALGER INSTITUTIONAL FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited)


   
Alger Capital
Appreciation
Institutional Fund
     
Alger Focus Equity
Fund
 
ASSETS:                
Investments in unaffiliated securities, at value (Identified cost below)* see accompanying schedules of investments


2,760,559,794



1,134,511,502
 
Investments in affiliated securities, at value (Identified cost below)** see accompanying schedules of investments
 
$
4,293,561
   
$
 
Cash and cash equivalents
   
34,654,700
     
76,515,826
 
Foreign cash †
   
319,381
     
 
Receivable for investment securities sold
   
10,334,742
     
5,756,155
 
Receivable for shares of beneficial interest sold
   
10,074,147
     
1,156,481
 
Dividends and interest receivable
   
821,323
     
78,132
 
Receivable from Investment Manager
   
30,242
     
5,900
 
Prepaid expenses
   
197,433
     
164,420
 
Total Assets
   
2,821,285,323
     
1,218,188,416
 
LIABILITIES:
               
Payable for investment securities purchased
   
43,091,765
     
17,729,839
 
Payable for shares of beneficial interest redeemed
   
6,706,112
     
1,624,208
 
Accrued investment advisory fees
   
1,894,224
     
562,215
 
Accrued distribution fees
   
169,243
     
65,194
 
Accrued shareholder servicing fees
   
442,359
     
11,287
 
Accrued shareholder administrative fees
   
25,159
     
11,602
 
Accrued administrative fees
   
69,187
     
29,733
 
Accrued custodian fees
   
29,906
     
15,259
 
Accrued transfer agent fees
   
1,935,545
     
137,467
 
Accrued printing fees
   
33,744
     
34,363
 
Accrued professional fees
   
35,724
     
26,307
 
Accrued trustee fees
   
7,924
     
3,126
 
Accrued fund accounting fees
   
120,964
     
58,365
 
Accrued tax payable
   
863
     
1,249
 
Accrued other expenses
   
5,190
     
2,367
 
Total Liabilities
   
54,567,909
     
20,312,581
 
NET ASSETS
 
$
2,766,717,414
   
$
1,197,875,835
 
NET ASSETS CONSIST OF:
               
Paid in capital (par value of $.001 per share)
   
1,820,251,461
     
1,115,774,220
 
Distributable earnings
   
946,465,953
     
82,101,615
 
NET ASSETS
 
$
2,766,717,414
   
$
1,197,875,835
 
* Identified cost
 
$
2,054,187,275(a
)
 
$
1,034,465,809(b
)
** Identified cost
 
$
3,075,000(a
)
 
$
345,713(b
)
† Cost of foreign cash
 
$
318,064
   
$
 

See Notes to Financial Statements.

- 37 -

Table of Contents
THE ALGER INSTITUTIONAL FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)

   
Alger Capital
Appreciation
Institutional Fund
   
Alger Focus Equity
Fund
 
NET ASSETS BY CLASS:
           
Class A
 
$
   
$
83,219,101
 
Class C
 
$
   
$
51,623,896
 
Class I
 
$
1,568,925,242
   
$
50,391,658
 
Class R
 
$
373,031,308
   
$
 
Class Y
 
$
415,714,368
   
$
150,907,642
 
Class Z
 
$
   
$
861,733,538
 
Class Z-2
 
$
409,046,496
   
$
 
SHARES OF BENEFICIAL INTEREST OUTSTANDING — NOTE 6:
 
Class A
   
     
1,949,877
 
Class C
   
     
1,324,732
 
Class I
   
50,962,407
     
1,171,643
 
Class R
   
15,189,302
     
 
Class Y
   
13,098,631
     
3,406,882
 
Class Z
   
     
19,509,195
 
Class Z-2
   
12,932,976
     
 
NET ASSET VALUE PER SHARE:
               
Class A — Net Asset Value Per Share Class A
 
$
   
$
42.68
 
Class A — Offering Price Per Share (includes a 5.25% sales charge)
 
$
   
$
45.04
 
Class C — Net Asset Value Per Share Class C
 
$
   
$
38.97
 
Class I — Net Asset Value Per Share Class I
 
$
30.79
   
$
43.01
 
Class R — Net Asset Value Per Share Class R
 
$
24.56
   
$
 
Class Y — Net Asset Value Per Share Class Y
 
$
31.74
   
$
44.29
 
Class Z — Net Asset Value Per Share Class Z
 
$
   
$
44.17
 
Class Z-2 — Net Asset Value Per Share Class Z-2
 
$
31.63
   
$
 
See Notes to Financial Statements.

(a)
At April 30, 2022, the net unrealized appreciation on investments, based on cost for federal income tax purposes of  2,078,819,136, amounted to 686,034,219 which consisted of aggregate gross unrealized appreciation of 921,015,137 and aggregate gross unrealized depreciation of 234,980,918.
(b)
At April 30, 2022, the net unrealized appreciation on investments, based on cost for federal income tax purposes of  1,045,744,960, amounted to 88,766,542 which consisted of aggregate gross unrealized appreciation of 187,143,905 and aggregate gross unrealized depreciation of 98,377,363.

- 38 -

Table of Contents
THE ALGER INSTITUTIONAL FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)


   
Alger Mid Cap
Growth Institutional
Fund
     
Alger Small Cap
Growth Institutional
Fund
 
ASSETS:                
Investments in unaffiliated securities, at value (Identified cost below)* see accompanying schedules of investments
 
$
65,564,282
   
$
198,626,655
 
Investments in affiliated securities, at value (Identified cost below)** see accompanying schedules of investments
   
1,094,879
     
2,252,482
 
Cash and cash equivalents
   
1,517,870
     
2,510,277
 
Receivable for investment securities sold
   
2,864,219
     
315,336
 
Receivable for shares of beneficial interest sold
   
22,103
     
134,898
 
Dividends and interest receivable
   
5,013
     
25,167
 
Receivable from Investment Manager
   
2,258
     
 
Prepaid expenses
   
11,491
     
65,166
 
Total Assets
   
71,082,115
     
203,929,981
 
LIABILITIES:
               
Payable for shares of beneficial interest redeemed
   
485,742
     
1,500,698
 
Accrued investment advisory fees
   
48,648
     
149,802
 
Accrued distribution fees
   
2,131
     
2,724
 
Accrued shareholder servicing fees
   
12,507
     
23,259
 
Accrued shareholder administrative fees
   
640
     
1,849
 
Accrued administrative fees
   
1,760
     
5,086
 
Accrued custodian fees
   
4,550
     
3,323
 
Accrued transfer agent fees
   
70,777
     
125,989
 
Accrued printing fees
   
5,827
     
21,234
 
Accrued professional fees
   
30,350
     
29,130
 
Accrued trustee fees
   
220
     
661
 
Accrued fund accounting fees
   
15,557
     
12,958
 
Accrued tax payable
   
1,178
     
1,295
 
Accrued other expenses
   
2,222
     
1,101
 
Total Liabilities
   
682,109
     
1,879,109
 
NET ASSETS
 
$
70,400,006
   
$
202,050,872
 
NET ASSETS CONSIST OF:
               
Paid in capital (par value of $.001 per share)
   
86,892,987
     
183,712,151
 
Distributable earnings (Distributions in excess of earnings)
   
(16,492,981
)
   
18,338,721
 
NET ASSETS
 
$
70,400,006
   
$
202,050,872
 
* Identified cost
 
$
72,087,407(a
)
 
$
188,590,972(b
)
** Identified cost
 
$
1,522,040(a
)
 
$
2,199,684(b
)
See Notes to Financial Statements.

- 39 -

Table of Contents
THE ALGER INSTITUTIONAL FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)

   
Alger Mid Cap Growth Institutional Fund
   
Alger Small Cap Growth Institutional
Fund
 
NET ASSETS BY CLASS:
           
Class I
 
$
50,081,434
   
$
94,510,378
 
Class R
 
$
4,728,958
   
$
6,008,171
 
Class Z-2
 
$
15,589,614
   
$
101,532,323
 
SHARES OF BENEFICIAL INTEREST OUTSTANDING — NOTE 6:
 
Class I
   
2,707,293
     
5,694,890
 
Class R
   
331,450
     
519,475
 
Class Z-2
   
815,009
     
5,982,706
 
 
NET ASSET VALUE PER SHARE:
               
Class I — Net Asset Value Per Share Class I
 
$
18.50
   
$
16.60
 
Class R — Net Asset Value Per Share Class R
 
$
14.27
   
$
11.57
 
Class Z-2 — Net Asset Value Per Share Class Z-2
 
$
19.13
   
$
16.97
 

See Notes to Financial Statements.
 
(a)
At April 30, 2022, the net unrealized depreciation on investments, based on cost for federal income tax purposes of 74,518,252, amounted to 7,859,091 which consisted of aggregate gross unrealized appreciation of 2,603,909 and aggregate gross unrealized depreciation of 10,463,000.
(b)
At April 30, 2022, the net unrealized appreciation on investments, based on cost for federal income tax purposes of 191,248,095, amounted to 9,631,042 which consisted of aggregate gross unrealized appreciation of 53,300,534 and aggregate gross unrealized depreciation of 43,669,492.

- 40 -

Table of Contents
THE ALGER INSTITUTIONAL FUNDS
Statements of Operations for the six months ended April 30, 2022 (Unaudited)

   
Alger Capital
Appreciation
Institutional
Fund
   
Alger Focus Equity
Fund
 
             
INCOME:
           
Dividends (net of foreign withholding taxes*)
 
$
8,202,313
   
$
3,020,395
 
Interest
   
2,909
     
10,353
 
Total Income
   
8,205,222
     
3,030,748
 
EXPENSES:
               
Investment advisory fees — Note 3(a)
   
12,920,759
     
3,814,327
 
Distribution fees — Note 3(c)
               
Class A
   
     
130,076
 
Class C
   
     
313,906
 
Class R
   
1,180,585
     
 
Shareholder servicing fees — Note 3(f)
   
3,070,630
     
88,229
 
Shareholder administrative fees — Note 3(f)
   
176,744
     
78,775
 
Administration fees — Note 3(b)
   
486,047
     
201,719
 
Custodian fees
   
63,220
     
32,155
 
Interest expenses
   
36,920
     
110
 
Transfer agent fees — Note 3(f)
   
1,019,194
     
133,370
 
Printing fees
   
36,365
     
41,475
 
Professional fees
   
76,405
     
34,780
 
Registration fees
   
98,321
     
64,070
 
Trustee fees — Note 3(g)
   
52,026
     
21,881
 
Fund accounting fees
   
254,017
     
125,325
 
Accrued taxes
   
297
     
297
 
Other expenses
   
43,906
     
18,488
 
Total Expenses
   
19,515,436
     
5,098,983
 
Less, expense reimbursements/waivers — Note 3(a)
   
(161,648
)
   
(27,327
)
Net Expenses
   
19,353,788
     
5,071,656
 
NET INVESTMENT LOSS
   
(11,148,566
)
   
(2,040,908
)
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY:
 
Net realized gain ( loss on unaffi ated nvestments
   
271,653,042
     
(81,693,609
)
Net realized gain on redemption-in-kind
   
     
77,070,975
 
Net realized gain on foreign currency transactions
   
9,489
     
2,472
 
Net change n unrea zed (deprec at on) on unaffi ated
               
investments
   
(1,297,950,419
)
   
(399,094,141
)
Net change unrealized (deprec at on) on affi ated
               
investments
   
(629,883
)
   
 
Net change in unrealized (depreciation) on foreign currency
   
(6,611
)
   
(2,927
)
Net realized and unrealized (loss) on investments and foreign currency
   
(1,026,924,382
)
   
(403,717,230
)
NET DECREASE IN NET ASSETS RESULTING FROM
               
OPERATIONS
 
$
(1,038,072,948
)
 
$
(405,758,138
)
* Foreign withholding taxes
 
$
115,273
   
$
 

See Notes to Financial Statements.

THE ALGER INSTITUTIONAL FUNDS
Statements of Operations for the six months ended April 30, 2022 (Unaudited) (Continued)
 
   
 Alger Mid Cap Growth
Institutional Fund
   
 Alger Small Cap
Growth Institutional
Fund
 
             
INCOME:
           
Dividends
 
$
130,306
   
$
317,738
 
Interest
   
280
     
995
 
Total Income
   
130,586
     
318,733
 
EXPENSES:
               
Investment advisory fees — Note 3(a)
   
350,308
     
1,080,912
 
Distribution fees — Note 3(c)
               
Class R
   
14,836
     
19,146
 
Shareholder servicing fees — Note 3(f)
   
90,135
     
173,566
 
Shareholder administrative fees — Note 3(f)
   
4,609
     
13,345
 
Administration fees — Note 3(b)
   
12,676
     
36,698
 
Custodian fees
   
9,109
     
11,239
 
Interest expenses
   
952
     
656
 
Transfer agent fees — Note 3(f)
   
39,756
     
78,994
 
Printing fees
   
3,726
     
15,480
 
Professional fees
   
16,816
     
21,135
 
Registration fees
   
55,747
     
26,830
 
Trustee fees — Note 3(g)
   
1,314
     
3,978
 
Fund accounting fees
   
33,706
     
42,101
 
Accrued taxes
   
297
     
297
 
Other expenses
   
8,832
     
8,184
 
Total Expenses
   
642,819
     
1,532,561
 
Less, expense reimbursements/waivers — Note 3(a)
   
(9,637
)
   
 
Net Expenses
   
633,182
     
1,532,561
 
NET INVESTMENT LOSS
   
(502,596
)
   
(1,213,828
)
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY:
 
Net rea zed ga n ( loss) on unaffi ated nvestments
   
(8,128,705
)
   
13,278,565
 
Net realized gain (loss) on foreign currency transactions
   
(197
)
   
7,124
 
Net change n unrealized (deprec at on) on unaffi ated investments
   
(30,702,431
)
   
(128,855,100
)
Net change n unrea zed (deprec at on) on affi ated investments
   
(165,330
)
   
(337,247
)
Net change in unrealized (depreciation) on foreign currency
   
(113
)
   
 
Net realized and unrealized (loss) on investments and foreign currency
   
(38,996,776
)
   
(115,906,658
)
NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS
 
$
(39,499,372
)
 
$
(117,120,486
)

See Notes to Financial Statements.

THE ALGER INSTITUTIONAL FUNDS
Statements of Changes in Net Assets (Unaudited)

    Alger Capital Appreciation Institutional Fund
 

 
For the
Six Months Ended
   
For the
Year Ended
 
   
April 30, 2022
   
October 31, 2021
 
Net investment loss
 
$
(11,148,566
)
 
$
(23,737,965
)
Net realized gain on investments and foreign currency
   
271,662,531
     
791,432,568
 
Net change in unrealized appreciation (depreciation) on investments and foreign currency
   
(1,298,586,913
)
   
440,334,204
 
Net increase (decrease) in net assets resulting from operations
   
(1,038,072,948
)
   
1,208,028,807
 
Dividends and distributions to shareholders:
               
Class I
   
(363,087,549
)
   
(334,101,515
)
Class R
   
(104,193,164
)
   
(93,628,884
)
Class Y
   
(107,008,462
)
   
(77,891,544
)
Class Z-2
   
(98,406,277
)
   
(83,783,950
)
Total dividends and distributions to shareholders
   
(672,695,452
)
   
(589,405,893
)
Increase (decrease) from shares of benefic a nterest transact ons:
               
Class I
   
205,807,159
     
(139,462,617
)
Class R
   
64,797,103
     
(38,173,960
)
Class Y
   
(4,335,899
)
   
92,435,215
 
Class Z-2
   
25,175,798
     
3,399,124
 
Net ncrease (decrease) from shares of benefic a nterest transactions — Note 6
   
291,444,161
     
(81,802,238
)
Total increase (decrease)
   
(1,419,324,239
)
   
536,820,676
 
Net Assets:
               
Beginning of period
   
4,186,041,653
     
3,649,220,977
 
END OF PERIOD
 
$
2,766,717,414
   
$
4,186,041,653
 

See Notes to Financial Statements.

THE ALGER INSTITUTIONAL FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)

    Alger Focus Equity Fund  
   
For the
Six Months Ended
April 30, 2022
   
For the
Year Ended
October 31, 2021
 
                 
Net investment loss
 
$
(2,040,908
)
 
$
(2,905,833
)
Net realized gain (loss) on investments, redemption-in-kind and
               
foreign currency
   
(4,620,162
)
   
203,135,590
 
Net change in unrealized appreciation (depreciation) on
               
investments and foreign currency
   
(399,097,068
)
   
212,034,428
 
Net increase (decrease) in net assets resulting from operations
   
(405,758,138
)
   
412,264,185
 
Dividends and distributions to shareholders:
               
Class A
   
(14,410,192
)
   
(5,562,411
)
Class C
   
(9,232,177
)
   
(4,078,168
)
Class I
   
(9,193,544
)
   
(4,326,616
)
Class Y
   
(23,615,638
)
   
(8,557,155
)
Class Z
   
(141,604,729
)
   
(50,310,167
)
Total dividends and distributions to shareholders
   
(198,056,280
)
   
(72,834,517
)
Increase (decrease) from shares of benefic a interest transact ons:
               
Class A
   
7,702,060
     
4,333,928
 
Class C
   
7,983,691
     
(1,734,591
)
Class I
   
(1,055,714
)
   
(2,647,367
)
Class Y
   
29,337,347
     
31,724,594
 
Class Z
   
128,358,363
     
180,694,073
 
Net increase from shares of benefic a interest transact ons - Note 6
   
172,325,747
     
212,370,637
 
Total increase (decrease)
   
(431,488,671
)
   
551,800,305
 
Net Assets:
               
Beginning of period
   
1,629,364,506
     
1,077,564,201
 
END OF PERIOD
 
$
1,197,875,835
   
$
1,629,364,506
 

See Notes to Financial Statements.

THE ALGER INSTITUTIONAL FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)

    Alger Mid Cap Growth Institutional Fund  

 
For the
Six Months Ended
   
For the
Year Ended
 
   
April 30, 2022
   
October 31, 2021
 
Net investment loss
 
$
(502,596
)
 
$
(1,265,616
)
Net realized gain (loss) on investments and foreign currency
   
(8,128,902
)
   
48,753,268
 
Net change in unrealized depreciation on investments and foreign currency
   
(30,867,874
)
   
(5,046,399
)
Net increase (decrease) in net assets resulting from operations
   
(39,499,372
)
   
42,441,253
 
Dividends and distributions to shareholders:
               
Class I
   
(33,226,128
)
   
(11,492,230
)
Class R
   
(3,288,321
)
   
(841,887
)
Class Z-2
   
(10,135,108
)
   
(2,277,430
)
Total dividends and distributions to shareholders
   
(46,649,557
)
   
(14,611,547
)
Increase (decrease) from shares of benefic a interest transact ons:
               
Class I
   
26,305,443
     
(22,600,674
)
Class R
   
3,144,826
     
(94,668
)
Class Z-2
   
8,906,742
     
3,284,423
 
Net increase (decrease) from shares of benefic a interest transactions — Note 6
   
38,357,011
     
(19,410,919
)
Total increase (decrease)
   
(47,791,918
)
   
8,418,787
 
Net Assets:
               
Beginning of period
   
118,191,924
     
109,773,137
 
END OF PERIOD
 
$
70,400,006
   
$
118,191,924
 

See Notes to Financial Statements.

THE ALGER INSTITUTIONAL FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)

    Alger Small Cap Growth Institutional Fund  
   
For the
Six Months Ended
   
For the
Year Ended
 
   
April 30, 2022
   
October 31, 2021
 
Net investment loss
 
$
(1,213,828
)
 
$
(3,289,096
)
Net realized gain on investments and foreign currency
   
13,285,689
     
59,633,392
 
Net change in unrealized appreciation (depreciation) on investments
   
(129,192,347
)
   
22,048,878
 
Net increase (decrease) in net assets resulting from operations
   
(117,120,486
)
   
78,393,174
 
Dividends and distributions to shareholders:
               
Class I
   
(28,859,482
)
   
(9,442,561
)
Class R
   
(2,153,880
)
   
(741,154
)
Class Z-2
   
(26,627,936
)
   
(6,376,030
)
Total dividends and distributions to shareholders
   
(57,641,298
)
   
(16,559,745
)
Increase (decrease) from shares of benefic a interest transact ons:
               
Class I
   
(82,888
)
   
(6,833,467
)
Class R
   
1,757,338
     
(2,219,896
)
Class Z-2
   
14,674,156
     
46,607,240
 
Net increase from shares of benefic a interest transact ons - Note 6
   
16,348,606
     
37,553,877
 
Total increase (decrease)
   
(158,413,178
)
   
99,387,306
 
Net Assets:
               
Beginning of period
   
360,464,050
     
261,076,744
 
END OF PERIOD
 
$
202,050,872
   
$
360,464,050
 

See Notes to Financial Statements.

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Capital Appreciation
Institutional Fund
  Class I  

 
Six months
ended 4/30/2022(i)
    Year ended 10/31/2021     Year ended 10/31/2020     Year ended 10/31/2019     Year ended 10/31/2018     Year ended 10/31/2017  
                                     
                                     
Net asset value, beginning of period
 
$
50.16
   
$
43.16
   
$
35.43
   
$
34.51
   
$
33.96
   
$
26.44
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.13
)
   
(0.29
)
   
(0.14
)
   
(0.07
)
   
(0.05
)
   
 
Net realized and unrealized gain (loss) on investments
   
(11.24
)
   
14.23
     
11.44
     
4.54
     
2.79
     
7.71
 
Total from investment operations
   
(11.37
)
   
13.94
     
11.30
     
4.47
     
2.74
     
7.71
 
Distributions from net realized gains
   
(8.00
)
   
(6.94
)
   
(3.57
)
   
(3.55
)
   
(2.19
)
   
(0.19
)
Net asset value, end of period
 
$
30.79
   
$
50.16
   
$
43.16
   
$
35.43
   
$
34.51
   
$
33.96
 
Total return
   
(26.65
)%
   
35.72
%
   
34.58
%
   
15.20
%
   
8.46
%
   
29.38
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000's omitted)
  $ 1,568,925     $ 2,313,493     $ 2,105,435     $ 2,028,574     $ 2,259,000     $ 2,451,822  
Ratio of gross expenses to average net assets
   
1.15
%
   
1.12
%
   
1.13
%
   
1.16
%
   
1.15
%
   
1.14
%
Ratio of expense reimbursements to average net assets
   
     
     
     
   
(iii)
     
 
Ratio of net expenses to average net assets
   
1.15
%
   
1.12
%
   
1.13
%
   
1.16
%
   
1.15
%
   
1.14
%
Ratio of net investment income (loss) to average net assets
   
(0.69
)%
   
(0.63
)%
   
(0.36
)%
   
(0.21
)%
   
(0.16
)%
   
0.01
%
Portfolio turnover rate
   
59.42
%
   
78.70
%
   
83.95
%
   
80.36
%
   
64.77
%
   
66.72
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Amount was less than 0.005% per share.

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Capital Appreciation
Institutional Fund
  Class R
 
   
Six months
ended 4/30/2022(i)
   
Year ended 10/31/2021
   
Year ended 10/31/2020
   
Year ended 10/31/2019
   
Year ended 10/31/2018
   
Year ended 10/31/2017
 
                                     
Net asset value, beginning of period
 
$
41.74
   
$
37.10
   
$
31.05
   
$
30.83
   
$
30.70
   
$
24.03
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.17
)
   
(0.41
)
   
(0.26
)
   
(0.20
)
   
(0.19
)
   
(0.13
)
Net realized and unrealized gain (loss) on investments
   
(9.01
)
   
11.99
     
9.88
     
3.97
     
2.51
     
6.99
 
Total from investment operations
   
(9.18
)
   
11.58
     
9.62
     
3.77
     
2.32
     
6.86
 
Distributions from net realized gains
   
(8.00
)
   
(6.94
)
   
(3.57
)
   
(3.55
)
   
(2.19
)
   
(0.19
)
Net asset value, end of period
 
$
24.56
   
$
41.74
   
$
37.10
   
$
31.05
   
$
30.83
   
$
30.70
 
Total return
   
(26.80
)%
   
35.10
%
   
33.99
%
   
14.69
%
   
7.96
%
   
28.78
%
RATIOS/SUPPLEMENTAL DATA:
 
Net assets, end of period (000's omitted)
 
$
373,031
   
$
553,283
   
$
520,172
   
$
525,018
   
$
595,010
   
$
654,966
 
Ratio of gross expenses to average net assets
   
1.57
%
   
1.56
%
   
1.58
%
   
1.61
%
   
1.59
%
   
1.62
%
Ratio of expense reimbursements to average net assets
   
     
     
     
   
(iii)
     
 
Ratio of net expenses to average net assets
   
1.57
%
   
1.56
%
   
1.58
%
   
1.61
%
   
1.59
%
   
1.62
%
Ratio of net investment loss to average net assets
    (1.11 )%    
(1.07
)%
   
(0.80
)%
   
(0.67
)%
   
(0.60
)%
   
(0.48
)%
Portfolio turnover rate
    59.42 %    
78.70
%
   
83.95
%
   
80.36
%
   
64.77
%
   
66.72
%

See Notes to Financial Statements

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Amount was less than 0.005% per share.

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Capital Appreciation
Institutional Fund
  Class Y  
 
 
Six months ended 4/30/2022(i)
    Year ended 10/31/2021     Year ended 10/31/2020     Year ended 10/31/2019     Year ended 10/31/2018    
From 2/28/2017 (commencement of operations) to 10/31/2017(ii)
 
                                     
Net asset value, beginning of period
 
$
51.36
   
$
43.91
   
$
35.86
   
$
34.75
   
$
34.05
   
$
28.85
 
 INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(iii)
    (0.06 )     (0.13 )   (iv)       0.05       0.08       0.02  
Net realized and unrealized gain (loss) on investments
    (11.56 )     14.52       11.62       4.61       2.81       5.18  
Total from investment operations
    (11.62 )     14.39       11.62       4.66       2.89       5.20  
Distributions from net realized gains
    (8.00 )     (6.94 )     (3.57 )     (3.55 )     (2.19 )      
Net asset value, end of period
  $ 31.74     $ 51.36     $ 43.91     $ 35.86     $ 34.75     $ 34.05  
Total return          
    (26.49 )%    
36.19
%
   
35.10
%
   
15.69
%
   
8.90
%
   
18.02
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000's omitted)
  $ 415,714    
$
678,853
   
$
484,362
   
$
337,299
   
$
166,778
   
$
97,889
 
Ratio of gross expenses to average net assets
    0.81 %     0.79 %     0.82 %     0.84 %     0.83 %     0.85 %
Ratio of expense reimbursements to average net assets
    (0.06 )%     (0.04 )%     (0.07 )%     (0.09 )%     (0.10 )%     (0.10 )%
Ratio of net expenses to average net assets 
    0.75 %     0.75 %     0.75 %     0.75 %     0.73 %     0.75 %
Ratio of net investment income (loss) to average net assets
    (0.29 )%     (0.27 )%    
(0.01
)%
   
0.14
%
   
0.22
%
   
0.10
%
Portfolio turnover rate
    59.42 %    
78.70
%
   
83.95
%
   
80.36
%
   
64.77
%
   
66.72
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(iii)
Amount was computed based on average shares outstanding during the period.
(iv)
Amount was less than 0.005 per share.

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Capital Appreciation
Institutional Fund
  Class Z-2               
 
   
Six months
ended 4/30/2022(i)
    Year ended 10/31/2021
    Year ended 10/31/2020
   
Year ended 10/31/2019
    Year ended 10/31/2018
   
Year ended 10/31/2017
 
                                     
Net asset value, beginning of period
 
$
51.23
   
$
43.83
   
$
35.82
   
$
34.74
   
$
34.08
   
$
26.44
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.07
)
    (0.14 )    
(0.02
)
   
0.03
      0.06      
0.07
 
Net realized and unrealized gain (loss) on investments
   
(11.53
)
   
14.48
     
11.60
     
4.60
     
2.79
     
7.76
 
Total from investment operations
   
(11.60
)
   
14.34
     
11.58
     
4.63
     
2.85
     
7.83
 
Distributions from net realized gains
   
(8.00
)
   
(6.94
)
   
(3.57
)
   
(3.55
)
   
(2.19
)
   
(0.19
)
Net asset value, end of period
  $ 31.63     $ 51.23     $ 43.83     $ 35.82     $ 34.74     $ 34.08  
Total return
   
(26.53
)
   
36.13
%
   
35.02
%
   
15.56
%
   
8.80
%
   
29.83
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000's omitted)
 
$
409,046
   
$
640,412
   
$
539,253
   
$
464,636
   
$
463,046
   
$
436,145
 
Ratio of gross expenses to average net assets
   
0.81
%
   
0.79
%
   
0.82
%
   
0.83
%
   
0.82
%
   
0.84
%
Ratio of expense reimbursements to average net assets
   
     
     
     
   
(iii)
     
 
Ratio of net expenses to average net assets
   
0.81
%
   
0.79
%
   
0.82
%
   
0.83
%
   
0.82
%
   
0.84
%
Ratio of net investment income (loss) to average net assets
   
(0.35
)%
   
(0.31
)%
   
(0.05
)%
   
0.10
%
   
0.16
%
   
0.22
%
Portfolio turnover rate
   
59.42
%
   
78.70
%
   
83.95
%
   
80.36
%
   
64.77
%
   
66.72
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Amount was less than 0.005% per share.
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Focus Equity Fund     Class A  
   
Six months
ended 4/30/2022(i)
   
Year ended 10/31/2021
     
  Year ended 10/31/2020     
  Year ended 10/31/2019     
  Year ended 10/31/2018      
 
Year ended 10/31/2017
  
                                     
Net asset value, beginning of period
 
$
65.10
   
$
50.77
   
$
37.33
    $ 34.00     $ 31.74    
$
23.95
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.14
)
   
(0.25
)
   
(0.07
)
 
(iii)
     
(0.06
)
    0.01  
Net realized and unrealized gain (loss) on investments
   
(14.32
)
   
17.97
     
14.29
     
4.95
     
3.55
     
7.78
 
Total from investment operations
   
(14.46
)
   
17.72
     
14.22
     
4.95
     
3.49
     
7.79
 
Dividends from net investment income
   
     
     
(0.02
)
   
     
     
 
Distributions from net realized gains
   
(7.96
)
   
(3.39
)
   
(0.76
)
   
(1.62
)
   
(1.23
)
   
 
Net asset value, end of period
  $ 42.68    
$
65.10
   
$
50.77
   
$
37.33
   
$
34.00
    $ 31.74  
Total return(iv)
    (25.17 )%     36.37 %    
38.75
%
   
15.56
%
   
11.33
%
   
32.53
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000's omitted)
  $ 83,219 $     $ 118,641    
$
89,028
      53,533     $ 43,621    
$
23,693
 
Ratio of gross expenses to average net assets
    0.94 %     0.92 %     0.95 %     1.00 %     1.03 %     1.11 %
Ratio of net expenses to average net assets
    0.94 %     0.92 %     0.95 %     1.00 %     1.03 %     1.11 %
Ratio of net investment income (loss) to average net assets
    (0.53 )%    
(0.43
)%
   
(0.16
)%
   
(0.01
)%
   
(0.17
)%
   
0.03
%
Portfolio turnover rate(v)
   
65.40
%
   
107.82
%
   
99.52
%
   
134.50
%
   
135.54
%
   
98.57
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Amount was less than 0.005 per share.
(iv)
Does not reflect the effect of sales charges, if applicable.
(v)
Portfolio turnover excludes the value of portfolio securities received or delivered as a result of in-kind fund share transactions.

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

 Alger Focus Equity Fund
  Class C
 
   
Six months
ended 4/30/2022(i)
    Year ended 10/31/2021
    Year ended 10/31/2020
    Year ended 10/31/2019
    Year ended 10/31/2018
   
Year ended 10/31/2017
 
                                     
Net asset value, beginning of period
 
$
60.35
   
$
47.63
   
$
35.30
   
$
32.47
   
$
30.59
   
$
23.27
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.31
)
   
(0.65
)
   
(0.38
)
   
(0.26
)
   
(0.31
)
   
(0.21
)
Net realized and unrealized gain (loss) on investments
   
(13.11
)
   
16.76
     
13.47
     
4.71
     
3.42
     
7.53
 
Total from investment operations
   
(13.42
)
   
16.11
     
13.09
     
4.45
     
3.11
     
7.32
 
Distributions from net realized gains
   
(7.96
)
   
(3.39
)
   
(0.76
)
   
(1.62
)
   
(1.23
)
   
 
Net asset value, end of period
 
$
38.97
   
$
60.35
   
$
47.63
   
$
35.30
   
$
32.47
   
$
30.59
 
Total return(iii)
    (25.46 )%    
35.33
%
   
37.73
%
   
14.68
%
   
10.51
%
   
31.46
%
RATIOS/SUPPLEMENTAL DATA:                                                
Net assets, end of period (000's omitted)
  $ 51,624    
$
70,664
   
$
57,067
   
$
37,169
   
$
26,366
   
$
18,660
 
Ratio of gross expenses to average net assets
    1.70 %    
1.68
%
   
1.71
%
   
1.75
%
   
1.80
%
   
1.90
%
Ratio of net expenses to average net assets
    1.70 %     1.68 %     1.71 %     1.75 %     1.80 %     1.90 %
Ratio of net investment loss to average net assets
    (1.29 )%    
(1.19
)%
   
(0.91
)%
   
(0.77
)%
   
(0.93
)%
   
(0.79
)%
Portfolio turnover rate(iv)
   
65.40
%
   
107.82
%
   
99.52
%
   
134.50
%
   
135.54
%
   
98.57
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Portfolio turnover excludes the value of portfolio securities received or delivered as a result of in-kind fund share transactions

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

 Alger Focus Equity Fund
  Class I
 
   
Six months
ended 4/30/2022(i)
    Year ended 10/31/2021     Year ended 10/31/2020    
Year ended 10/31/2019
    Year ended 10/31/2018     Year ended 10/31/2017  
Net asset value, beginning of period
 
$
65.54
   
$
51.07
   
$
37.56
   
$
34.17
   
$
31.88
   
$
24.06
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.12
)
   
(0.23
)
   
(0.03
)
   
0.01
     
(0.05
)
   
0.01
 
Net realized and unrealized gain (loss) on investments
   
(14.45
)
   
18.09
     
14.37
     
5.00
     
3.57
     
7.81
 
Total from investment operations
   
(14.57
)
   
17.86
     
14.34
     
5.01
     
3.52
     
7.82
 
Dividends from net investment income
   
   
(iii)
     
(0.07
)
   
     
     
 
Distributions from net realized gains
   
(7.96
)
   
(3.39
)
   
(0.76
)
   
(1.62
)
   
(1.23
)
   
 
Net asset value, end of period
 
$
43.01
   
$
65.54
   
$
51.07
   
$
37.56
   
$
34.17
   
$
31.88
 
Total return(iv)
    (25.17 )%    
36.44
%
   
38.81
%
   
15.66
%
   
11.40
%
   
32.50
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000's omitted)
  $ 50,392    
$
77,895
   
$
63,658
   
$
68,705
   
$
37,070
   
$
23,952
 
Ratio of gross expenses to average net assets
    0.91 %     0.89 %     0.93 %     0.96 %     1.02 %     1.12 %
Ratio of expense reimbursements to average net assets
   
      (0.01 )%     (0.04 )%     (0.04 )%     (0.02 )%      
Ratio of net expenses to average net assets
    0.91 %     0.88 %     0.89 %     0.92 %     1.00 %     1.12 %
Ratio of net investment income (loss) to average net assets
    (0.43 )%    
(0.39
)%
   
(0.06
)%
   
0.04
%
   
(0.13
)%
   
0.02
%
Portfolio turnover rate(v)
   
65.40
%
           
99.52
%
   
134.50
%
   
135.54
%
   
98.57
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Amount was less than 0.005 per share.
(iv)
Does not reflect the effect of sales charges, if applicable.
(v)
Portfolio turnover excludes the value of portfolio securities received or delivered as a result of in-kind fund share transactions.

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Focus Equity Fund   Class Y  
    Six months ended 4/30/2022(i)     Year ended 10/31/2021     Year ended 10/31/2020     Year ended 10/31/2019     Year ended 10/31/2018    
From 2/28/2017 (commencement of operations) to 10/31/2017(ii)
 
Net asset value, beginning of period
 
$
67.15
   
$
52.12
   
$
38.29
   
$
34.79
   
$
32.33
   
$
26.86
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(iii)
   
(0.05
)
   
(0.06
)
   
0.07
     
0.12
     
0.04
     
(0.01
)
Net realized and unrealized gain (loss) on investments
   
(14.85
)
   
18.50
     
14.65
     
5.08
     
3.65
     
5.48
 
Total from investment operations
   
(14.90
)
   
18.44
     
14.72
     
5.20
     
3.69
     
5.47
 
Dividends from net investment income
   
     
(0.02
)
   
(0.13
)
   
(0.08
)
   
     
 
Distributions from net realized gains
   
(7.96
)
   
(3.39
)
   
(0.76
)
   
(1.62
)
   
(1.23
)
   
 
Net asset value, end of period
 
$
44.29
   
$
67.15
   
$
52.12
   
$
38.29
   
$
34.79
   
$
32.33
 
Total return(iv)
   
(25.04
)%
   
36.84
%
   
39.17
%
   
15.97
%
   
11.78
%
   
20.36
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000's omitted)
 
$
150,908
   
$
194,908
   
$
121,688
   
$
69,175
   
$
57,880
   
$
4,319
 
Ratio of gross expenses to average net assets
   
0.61
%
   
0.61
%
   
0.63
%
   
0.66
%
   
0.70
%
   
1.51
%
Ratio of expense reimbursements to average net assets
   
(0.03
)%
   
(0.03
)%
   
     
(0.01
)%
   
(0.05
)%
   
(0.86
)%
Ratio of net expenses to average net assets
   
0.58
%
   
0.58
%
   
0.63
%
   
0.65
%
   
0.65
%
   
0.65
%
Ratio of net investment income (loss) to average net assets
   
(0.17
)%
   
(0.10
)%
   
0.16
%
   
0.34
%
   
0.11
%
   
(0.05
)%
Portfolio turnover rate(v)
   
65.40
%
   
107.82
%
   
99.52
%
   
134.50
%
   
135.54
%
   
98.57
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(iii)
Amount was computed based on average shares outstanding during the period.
(iv)
Does not reflect the effect of sales charges, if applicable.
(v)
Portfolio turnover excludes the value of portfolio securities received or delivered as a result of in-kind fund share transactions.

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

 Alger Focus Equity Fund
  Class Z
 
   
Six months
ended
4/30/2022(i)
    Year ended 10/31/2021     Year ended 10/31/2020     Year ended 10/31/2019     Year ended 10/31/2018     Year ended 10/31/2017  
                                     
Net asset value, beginning of period
 
$
67.00
   
$
52.02
   
$
38.21
   
$
34.73
   
$
32.28
   
$
24.30
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.06
)
   
(0.08
)
   
0.06
     
0.11
     
0.05
     
0.07
 
Net realized and unrealized gain (loss) on investments
   
(14.81
)
   
18.47
     
14.64
     
5.07
     
3.63
     
7.91
 
Total from investment operations
   
(14.87
)
   
18.39
     
14.70
     
5.18
     
3.68
     
7.98
 
Dividends from net investment income
   
     
(0.02
)
   
(0.13
)
   
(0.08
)
   
     
 
Distributions from net realized gains
   
(7.96
)
   
(3.39
)
   
(0.76
)
   
(1.62
)
   
(1.23
)
   
 
Net asset value, end of period
 
$
44.17
   
$
67.00
   
$
52.02
     
38.21
   
$
34.73
   
$
32.28
 
Total return(iii)
   
(25.06
)%
   
36.81
%
   
39.20
%
   
15.93
%
   
11.74
%
   
32.84
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000's omitted)
 
$
861,734 $
      1,167,256    
$
746,122
   
$
351,530
   
$
172,900
   
$
61,721
 
Ratio of gross expenses to average net assets
   
0.61
%
   
0.61
%
   
0.63
%
   
0.66
%
   
0.71
%
   
0.84
%
Ratio of expense reimbursements to average net assets
   
     
     
     
     
(0.02
)%
   
 
Ratio of net expenses to average net assets
   
0.61
%
   
0.61
%
   
0.63
%
   
0.66
%
   
0.69
%
   
0.84
%
Ratio of net investment income (loss) to average net assets
   
(0.20
)%
   
(0.13
)%
   
0.13
%
   
0.29
%
   
0.15
%
   
0.25
%
Portfolio turnover rate(iv)
   
65.40
%
   
107.82
%
   
99.52
%
   
134.50
%
   
135.54
%
   
98.57
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Portfolio turnover excludes the value of portfolio securities received or delivered as a result of in-kind fund share transactions.

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Mid Cap Growth Institutional Fund
  Class I
 
   
Six months
ended
4/30/2022(i)
      
Year ended 10/31/2021
     
 
Year ended 10/31/2020
       
Year ended 10/31/2019
       
Year ended 10/31/2018
    
 
Year ended 10/31/2017
     
                                     
Net asset value, beginning of period
 
$
50.80
   
$
40.47
   
$
31.04
   
$
30.20
   
$
28.65
   
$
21.59
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.15
)
   
(0.45
)
   
(0.27
)
   
(0.21
)
   
(0.25
)
   
(0.13
)
Net realized and unrealized gain (loss) on investments
   
(12.30
)
   
16.11
     
12.27
     
3.03
     
1.80
     
7.19
 
Total from investment operations
   
(12.45
)
   
15.66
     
12.00
     
2.82
     
1.55
     
7.06
 
Distributions from net realized gains
   
(19.85
)
   
(5.33
)
   
(2.57
)
   
(1.98
)
   
     
 
Net asset value, end of period
 
$
18.50
   
$
50.80
   
$
40.47
   
$
31.04
   
$
30.20
   
$
28.65
 
Total return     (34.74 )%

41.08 %

41.71 %

10.76 %

5.44 %

32.70 %
RATIOS/SUPPLEMENTAL DATA:                                                
Net assets, end of period (000's omitted)
  $ 50,081    
$
85,297
   
$
86,228
   
$
73,274
   
$
79,954
   
$
85,890
 
Ratio of gross expenses to average net assets
    1.44 %    
1.27
%
   
1.35
%
   
1.35
%
   
1.34
%
   
1.28
%
Ratio of net expenses to average net assets
    1.44 %     1.27 %     1.35 %     1.35 %     1.34 %     1.28 %
Ratio of net investment loss to average net assets
   
(1.16
)%
   
(0.97
)%
   
(0.80
)%
   
(0.70
)%
   
(0.80
)%
   
(0.50
)%
Portfolio turnover rate
   
126.78
%
   
171.43
%
   
180.30
%
   
182.64
%
   
127.57
%
   
157.49
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Mid Cap Growth Institutional Fund
  Class R
 
   
Six months
ended
4/30/2022(i)
    
Year ended 10/31/2021
    
Year ended 10/31/2020
    
Year ended 10/31/2019
    
Year ended 10/31/2018
    
Year ended 10/31/2017
     
Net asset value, beginning of period
 
$
44.37
   
$
36.07
   
$
28.06
   
$
27.64
   
$
26.35
   
$
19.96
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.16
)
   
(0.59
)
   
(0.36
)
   
(0.32
)
   
(0.36
)
   
(0.24
)
Net realized and unrealized gain (loss) on investments
   
(10.09
)
   
14.22
     
10.94
     
2.72
     
1.65
     
6.63
 
Total from investment operations
   
(10.25
)
   
13.63
     
10.58
     
2.40
     
1.29
     
6.39
 
Distributions from net realized gains
   
(19.85
)
   
(5.33
)
   
(2.57
)
   
(1.98
)
   
     
 
Net asset value, end of period
 
$
14.27
   
$
44.37
   
$
36.07
   
$
28.06
   
$
27.64
   
$
26.35
 
Total return
    (34.89 )%    
40.42
%
   
41.03
%
   
10.24
%
   
4.90
%
   
32.01
%
RATIOS/SUPPLEMENTAL DATA:                                                
Net assets, end of period (000's omitted)
  $ 4,729    
$
7,426
   
$
6,093
   
$
7,952
   
$
10,672
   
$
12,943
 
Ratio of gross expenses to average net assets
    1.87 %    
1.75
%
   
1.83
%
   
1.85
%
   
1.82
%
   
1.81
%
Ratio of net expenses to average net assets
    1.87 %     1.75 %     1.83 %     1.85 %     1.82 %     1.81 %
Ratio of net investment loss to average net assets
   
(1.59
)%
   
(1.46
)%
   
(1.22
)%
   
(1.18
)%
   
(1.28
)%
   
(1.04
)%
Portfolio turnover rate
   
126.78
%
   
171.43
%
   
180.30
%
   
182.64
%
   
127.57
%
   
157.49
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Mid Cap Growth Institutional Fund
    Class Z-2 
 
     
Six months
ended
4/30/2022(i)
    

Year ended 10/31/2021
 
    

Year ended 10/31/2020
 
    

Year ended 10/31/2019
 
    

Year ended 10/31/2018
 
    

Year ended 10/31/2017
 
    
Net asset value, beginning of period
 
$
51.68
   
$
40.99
   
$
31.31
   
$
30.36
   
$
28.72
   
$
21.59
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.10
)
   
(0.32
)
   
(0.16
)
   
(0.12
)
   
(0.17
)
   
(0.08
)
Net realized and unrealized gain (loss) on investments
   
(12.60
)
   
16.34
     
12.41
     
3.05
     
1.81
     
7.21
 
Total from investment operations
   
(12.70
)
   
16.02
     
12.25
     
2.93
     
1.64
     
7.13
 
Distributions from net realized gains
   
(19.85
)
   
(5.33
)
   
(2.57
)
   
(1.98
)
   
     
 
Net asset value, end of period
 
$
19.13
   
$
51.68
   
$
40.99
   
$
31.31
   
$
30.36
   
$
28.72
 
Total return
   
(34.59
)%
   
41.50
%
   
42.18
%
   
11.08
%
   
5.74
%
   
33.02
%
RATIOS/SUPPLEMENTAL DATA:
                                   
Net assets, end of period (000's omitted)
 
$
15,590 $
     
25,469
   
$
17,452
   
$
12,409
   
$
11,316
   
$
8,810
 
Ratio of gross expenses to average net assets
   
1.09
%
   
0.97
%
   
1.05
%
   
1.09
%
   
1.08
%
   
1.14
%
Ratio of expense reimbursements to average net assets
   
(0.10
)%
   
     
(0.01
)%
   
(0.04
)%
   
(0.03
)%
   
(0.09
)%
Ratio of net expenses to average net assets
   
0.99
%
   
0.97
%
   
1.04
%
   
1.05
%
   
1.05
%
   
1.05
%
Ratio of net investment loss to average net assets
   
(0.71
)%
   
(0.68
)%
   
(0.48
)%
   
(0.40
)%
   
(0.53
)%
   
(0.31
)%
Portfolio turnover rate
   
126.78
%
   
171.43
%
   
180.30
%
   
182.64
%
   
127.57
%
   
157.49
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Mid Cap Growth Institutional Fund    
Class I
 
     
Six months
ended
4/30/2022(i)
    

Year ended 10/31/2021
    

Year ended 10/31/2020
    

Year ended 10/31/2019
    

Year ended 10/31/2018
        
Year ended 10/31/2017
    
Net asset value, beginning of period
 
$
31.70
   
$
25.77
   
$
21.49
   
$
22.53
   
$
20.52
   
$
14.83
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.12
)
   
(0.32
)
   
(0.24
)
   
(0.25
)
   
(0.22
)
   
(0.14
)
Net realized and unrealized gain (loss) on investments
   
(9.62
)
   
7.80
     
8.32
     
1.95
     
2.81
     
5.83
 
Total from investment operations
   
(9.74
)
   
7.48
     
8.08
     
1.70
     
2.59
     
5.69
 
Dividends from net investment income
   
     
     
(0.03
)
   
     
     
 
Distributions from net realized gains
   
(5.36
)
   
(1.55
)
   
(3.77
)
   
(2.74
)
   
(0.58
)
   
 
Net asset value, end of period
 
$
16.60
   
$
31.70
   
$
25.77
   
$
21.49
   
$
22.53
   
$
20.52
 
Total return
   
(34.99
)%
   
29.64
%
   
44.12
%
   
10.20
%
   
12.96
%
   
38.37
%
RATIOS/SUPPLEMENTAL DATA:
                                   
Net assets, end of period (000's omitted)
 
$
94,510
   
$
180,795
   
$
152,183
   
$
95,853
   
$
132,526
   
$
130,527
 
Ratio of gross expenses to average net assets
   
1.30
%
   
1.24
%
   
1.30
%
   
1.35
%
   
1.32
%
   
1.32
%
Ratio of net expenses to average net assets
   
1.30
%
   
1.24
%
   
1.30
%
   
1.35
%
   
1.32
%
   
1.32
%
Ratio of net investment loss to average net assets
   
(1.07
)%
   
(1.04
)%
   
(1.10
)%
   
(1.16
)%
   
(1.00
)%
   
(0.77
)%
Portfolio turnover rate
   
11.38
%
   
41.10
%
   
23.78
%
   
14.93
%
   
28.20
%
   
29.70
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized
(ii)
Amount was computed based on average shares outstanding during the period.

THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Mid Cap Growth Institutional Fund  
Class R
 
   
 Six months
ended
4/30/2022(i)
      
 
Year ended 10/31/2021
      
 
Year ended 10/31/2020
      
 
Year ended 10/31/2019
      
 
Year ended 10/31/2018
      
 
Year ended 10/31/2017
    
                                     
Net asset value, beginning of period
 
$
24.00
   
$
19.92
   
$
17.48
   
$
18.97
   
$
17.44
   
$
12.67
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.11
)
   
(0.35
)
   
(0.27
)
   
(0.28
)
   
(0.27
)
   
(0.19
)
Net realized and unrealized gain (loss) on investments
   
(6.96
)
   
5.98
     
6.48
     
1.53
     
2.38
     
4.96
 
Total from investment operations
   
(7.07
)
   
5.63
     
6.21
     
1.25
     
2.11
     
4.77
 
Distributions from net realized gains
   
(5.36
)
   
(1.55
)
   
(3.77
)
   
(2.74
)
   
(0.58
)
   
 
Net asset value, end of period
 
$
11.57
   
$
24.00
   
$
19.92
   
$
17.48
   
$
18.97
   
$
17.44
 
Total return
    (35.11 )%    
29.02
%
   
43.38
%
   
9.67
%
   
12.48
%
   
37.65
%
RATIOS/SUPPLEMENTAL DATA:                                                
Net assets, end of period (000's omitted)
  $ 6,008 $      
9,751
   
$
9,940
   
$
8,690
   
$
9,238
   
$
11,253
 
Ratio of gross expenses to average net assets 
    1.71 %    
1.73
%
   
1.80
%
   
1.81
%
   
1.77
%
   
1.82
%
Ratio of net expenses to average net assets
    1.71 %     1.73 %     1.80 %     1.81 %     1.77 %     1.82 %
Ratio of net investment loss to average net assets
    (1.47)%
     
(1.51
)%
   
(1.58
)%
   
(1.63
)%
   
(1.44
)%
   
(1.27
)%
Portfolio turnover rate
   
11.38
%
   
41.10
%
   
23.78
%
   
14.93
%
   
28.20
%
   
29.70
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.

Alger Mid Cap Growth Institutional Fund  
Class Z-2
 
   
Six months
ended
4/30/2022(i)
      
Year ended 10/31/2021
      
Year ended 10/31/2020
      
Year ended 10/31/2019
      
Year ended 10/31/2018
      
Year ended 10/31/2017
    
Net asset value, beginning of period
 
$
32.23
   
$
26.10
   
$
21.76
   
$
22.70
   
$
20.60
   
$
14.84
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.08
)
   
(0.24
)
   
(0.18
)
   
(0.17
)
   
(0.15
)
   
(0.09
)
Net realized and unrealized gain (loss) on investments
   
(9.82
)
   
7.92
     
8.42
     
1.97
     
2.83
     
5.85
 
Total from investment operations
   
(9.90
)
   
7.68
     
8.24
     
1.80
     
2.68
     
5.76
 
Dividends from net investment income
   
     
     
(0.13
)
   
     
     
 
Distributions from net realized gains
   
(5.36
)
   
(1.55
)
   
(3.77
)
   
(2.74
)
   
(0.58
)
   
 
Net asset value, end of period
 
$
16.97
   
$
32.23
   
$
26.10
   
$
21.76
   
$
22.70
   
$
20.60
 
Total return
    (34.89 )%    
30.05
%
   
44.55
%
   
10.61
%
   
13.35
%
   
38.81
%
RATIOS/SUPPLEMENTAL DATA:                                                
Net assets, end of period (000's omitted) 
  $ 101,532    
$
169,918
   
$
98,954
   
$
47,863
   
$
49,552
   
$
67,268
 
Ratio of gross expenses to average net assets
    0.95 %     0.94 %     0.99 %     1.02 %     1.00 %     1.03 %
Ratio of expense reimbursements to average net assets
   
            (0.01 )%     (0.03 )%     (0.01 )%     (0.04 )%
Ratio of net expenses to average net assets
    0.95 %     0.94 %     0.98 %     0.99 %     0.99 %     0.99 %
Ratio of net investment loss to average net assets
    (0.71 )%    
(0.76
)%
 
(0.79)%`
     
(0.81
)%
   
(0.66
)%
   
(0.51
)%
Portfolio turnover rate
   
11.38
%
   
41.10
%
   
23.78
%
   
14.93
%
   
28.20
%
   
29.70
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited)

NOTE 1 — General: 

The Alger Institutional Funds (the “Trust”) is an open-end registered investment company organized as a business trust under the laws of the Commonwealth of Massachusetts. The Trust qualifies as an investment company as defined in Financial Accounting Standards Board ("FASB") Accounting Standards Codification 946 - Financial Services - Investment Companies. The Trust operates as a series company currently offering an unlimited number of shares of beneficial interest in four series - Alger Capital Appreciation Institutional Fund, Alger Focus Equity Fund, Alger Mid Cap Growth Institutional Fund and Alger Small Cap Growth Institutional Fund (collectively, the “Funds” or individually, each a “Fund”). The Funds normally invest primarily in equity securities and each has an investment objective of long-term capital appreciation.
 
Each Fund offers one or more of the following share classes: Class A, C, I, R, Y, Z and Z-2. Class A shares are generally subject to an initial sales charge while Class C shares are generally subject to a deferred sales charge. Class I, R, Y, Z and Z-2 shares are sold to institutional investors without an initial or deferred sales charge and Class Y, Z and Z-2 shares are generally subject to a minimum initial investment of $500,000. Class C shares will automatically convert to Class A shares on the fifth business day of the month following the eighth anniversary of the purchase date of a shareholder’s Class C shares, without the imposition of any sales load, fee or other charge. Class C shares held at certain dealers may not convert to Class A shares or may be converted on a different schedule. At conversion, a proportionate amount of shares representing reinvested dividends and distributions will also be converted into Class A shares. Each class has identical rights to assets and earnings, except that each share class bears the pro rata allocation of the Fund's expenses other than a class expense (not including advisory or custodial fees or other expenses related to the management of the Fund’s assets).
 
NOTE 2 - Significant Accounting Policies:
 
(a) Investment Valuation: The Funds value their financial instruments at fair value using independent dealers or pricing services under policies approved by the Trust’s Board of Trustees (the “Board”). Investments held by the Funds are valued on each day the New York Stock Exchange (the "NYSE") is open, as of  the close of  the NYSE (normally 4:00
p.m. Eastern Time).
 
Investments in money market funds and short-term securities held by the Funds having a remaining maturity of sixty days or less are valued at amortized cost which approximates market value.
 
Equity securities, including traded rights, warrants and option contracts for which valuation information is readily available, are valued at the last quoted sales price or official closing price on the primary market or exchange on which they are traded as reported by an independent pricing service. In the absence of quoted sales, such securities are valued at the bid price or, in the absence of a recent bid price, the equivalent as obtained from one or more of the major market makers for the securities to be valued.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Debt securities generally trade in the over-the-counter market. Debt securities with remaining maturities of more than sixty days at the time of acquisition are valued on the basis of  the last available bid prices or current market quotations provided by dealers or pricing services. In determining the value of a particular investment, pricing services may use certain information with respect to transactions in such investments, quotations from dealers, pricing matrixes, market transactions in comparable investments, various relationships observed in the market between investments and calculated yield measures based on valuation technology commonly employed in the market for such investments. Debt securities with a remaining maturity of sixty days or less are valued at amortized cost which approximates market value.
 
Securities for which market quotations are not readily available are valued at fair value, as determined in good faith pursuant to procedures established by the Board and described further herein.
 
Securities in which the Funds invest may be traded in foreign markets that close before the close of the NYSE. Developments that occur between the close of the foreign markets and the close of the NYSE may result in adjustments to the closing foreign prices to reflect what the Trust’s investment adviser, pursuant to policies established by the Board, believes to be the fair value of these securities as of the close of the NYSE. The Funds may also fair value securities in other situations, for example, when a particular foreign market is closed but the Funds are open.
 
FASB Accounting Standards Codification 820 - Fair Value Measurements and Disclosures ("ASC 820") defines fair value  as  the price that  the Funds  would receive  upon  selling an investment in a timely transaction to an independent buyer in the principal or most advantageous market of the investment. ASC 820 established a three-tier hierarchy to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability and may be observable or unobservable. Observable inputs are based on market data obtained from sources independent of the Funds. Unobservable inputs are inputs  that reflect the Funds' own assumptions based on the best information available in the circumstances. The three-tier hierarchy of inputs is summarized in the three broad Levels listed below.
 

Level 1 - quoted prices in active markets for identical investments
 

Level 2 - significant other observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)
 

Level 3 - significant unobservable inputs (including the Funds' own assumptions in determining the fair value of investments)
 
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
 
The Funds’ valuation techniques are generally consistent with either the market or the income approach to fair value. The market approach considers prices and other relevant information generated by market  transactions  involving identical or comparable  assets  to measure fair value. The income approach converts future amounts to a current, or discounted, single amount. These fair value measurements are determined on the basis of the value indicated by current market expectations about such future events. Inputs for Level 1 include exchange-listed prices and broker quotes in an active market. Inputs for Level 2 include the last trade price in the case of a halted security, an exchange-listed price which has been adjusted for fair value factors, and prices of closely related securities. Additional Level 2 inputs include an evaluated price which is based upon a compilation of observable market information such as spreads for fixed income and preferred securities. Inputs for Level 3 include, but are not limited to, revenue multiples, earnings before interest, taxes, depreciation and amortization ("EBITDA") multiples, discount rates, time to exit and the probabilities of success of certain outcomes. Such unobservable market information may be obtained from a company's financial statements and from industry studies, market data, and market indicators such as benchmarks and indexes. Because of the inherent uncertainty and often limited markets for restricted securities, the valuations assigned to such securities by the Funds may significantly differ from the valuations that would have been assigned by the Funds had there been an active market for such securities.
 
Valuation processes are determined by a Valuation Committee (“Committee”) authorized by the Board and comprised of representatives of the Trust's investment adviser and officers of the Trust. The Committee reports its fair value determinations and related valuation information to the Board. The Board is responsible for approving the valuation policy and procedures.
 
While Committee meetings are held on an as-needed basis, the Committee generally meets quarterly to review and evaluate the effectiveness of the procedures for making fair value determinations. The Committee considers, among other things, the results of quarterly back testing of the fair value model for foreign securities, pricing comparisons between primary and secondary price sources, the outcome of price challenges put to the Funds’ pricing vendor, and variances between transactional prices and the previous day’s prices.
 
In December 2020, the Securities and Exchange Commission adopted Rule 2a-5 under the Investment Company Act of 1940, as amended (the “1940 Act”), which is intended to address valuation practices and the role of the board of directors with respect to the fair value of the investments of a registered investment company. Among other things, Rule 2a-5 will permit the Board to designate the Funds’ investment adviser, Fred Alger Management, LLC ("Alger Management" or the "Investment Manager"), to perform the Funds' fair value determinations, which will be subject to the Board’s oversight and certain reporting and other requirements intended to ensure that the Board receives the information it needs to oversee the Investment Manager’s fair value determinations. Compliance with Rule 2a-5 will not be required until September 2022. The Funds, the Board, and the Investment Manager are currently in the process of implementing the requirements of Rule 2a-5 for compliance with these requirements by the September 2022 compliance deadline.
 
(b)   Cash and Cash Equivalents: Cash and cash equivalents include U.S. dollars, foreign cash and overnight time deposits.
 
(c)   Securities Transactions and Investment Income: Securities transactions are recorded on a  trade date basis. Realized gains and losses from securities transactions are recorded on the identified cost basis. Dividend income is recognized on the ex-dividend date and interest income is recognized on the accrual basis.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Premiums and discounts on debt securities purchased are amortized or accreted over the lives of the respective securities.
 
(d)   Foreign Currency Transactions: The books and records of the Funds are maintained in U.S. dollars. Foreign currencies, investments and other assets and liabilities are translated into U.S. dollars at the prevailing rates of exchange on the valuation date. Purchases and sales of investment securities and income and expenses are translated into U.S. dollars at the prevailing exchange rates on the respective dates of such transactions.
 
Net realized gains and losses on foreign currency transactions represent net gains and losses from the disposition of foreign currencies, currency gains and losses realized between the trade dates and settlement dates of security transactions, and the difference between the amount of net investment income accrued and the U.S. dollar amount actually received. The effects of  changes in foreign currency exchange rates on investments in securities   are included in realized and unrealized gain or loss on investments in the accompanying Statements of Operations.
 
(e)   Dividends to Shareholders: Dividends and distributions payable to shareholders are recorded by the Funds on the ex-dividend date. Dividends from net investment income, if available, and distributions from net realized gains, offset by any loss carryforward, are declared and paid annually after the end of the fiscal year in which earned.
 
Each share class is treated separately in determining the amount of  dividends from net investment income payable to holders of its shares.
 
The characterization of distributions to shareholders for financial reporting purposes is determined in accordance with federal income tax rules. Therefore, the source of a Fund's distributions may be shown in the accompanying financial statements as either from, or in excess of, net investment income, net realized gain on investment transactions, or return of capital, depending on the type of book/tax differences that may exist. Capital accounts within the financial statements are adjusted for permanent book/tax differences. Reclassifications result primarily from the differences in tax treatment of net operating losses, passive foreign investment companies, and foreign currency transactions. The reclassifications are done annually at year-end and have no impact on the net asset values of the Funds and are designed to present each Fund's capital accounts on a tax basis.
 
(f)   Federal Income Taxes: It is each Fund’s policy to comply with the requirements of the Internal Revenue Code Subchapter M applicable to regulated investment companies and to distribute all of its taxable income to its shareholders. Provided that the Funds maintain such compliance, no federal income tax is required. Each Fund is treated as a separate entity for the purpose of determining such compliance.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

FASB Accounting Standards Codification 740 - Income  Taxes  ("ASC  740")  requires the Funds to measure and recognize in their financial statements the benefit of a tax position taken (or expected to be taken) on an income tax return if such position will more likely than not be sustained upon examination based on the technical merits of the position. No tax years are currently under investigation. The Funds file income tax returns in the U.S. Federal jurisdiction, as well as the New York State and New York City jurisdictions. The statute of limitations on the Funds' tax returns remains open for the tax years 2018-2021. Management does not believe there are any uncertain tax positions that require recognition of a tax liability.
 
(g)   Allocation Methods: The Trust accounts separately for the assets, liabilities and operations of each Fund. Expenses directly attributable to each Fund are charged to that Fund's operations; expenses which are applicable to all Funds are allocated among them based on net assets. Income, realized and unrealized gains and losses, and expenses of each Fund are allocated among the Fund's classes based on relative net assets, with the exception of distribution fees, transfer agency fees, and shareholder servicing and related fees.
 
(h)  Estimates: These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which require using estimates and assumptions that affect the reported amounts therein. These unaudited interim financial statements reflect all adjustments that are, in the opinion of management, necessary to present a fair statement of results for the interim period. Actual results may differ from those estimates. All such estimates are of a normal recurring nature.
 
NOTE 3 - Investment Advisory Fees and Other Transactions with Afffiliates:
 
(a)   Investment Advisory Fees:  Fees  incurred by each Fund, pursuant to the provisions of the Trust’s Investment Advisory Agreement with the Investment Manager, are payable monthly and computed based on the following rates. The actual rate paid as a percentage of average daily net assets, for the six months ended April 30, 2022, is set forth below under the heading “Actual Rate”:
 
   Tier 1   Tier 2
   Tier 3   
  Tier 4     Tier 5    Actual Rate
Alger Capital Appreciation Institutional Fund(a)
0.81%
0.65%
0.60%
0.55%
0.45%
0.73%
Alger Focus Equity
Fund(b)
 
0.52%
 
 
 
 
 
0.52%
Alger Mid Cap
Growth Institutional Fund(c)
0.76%
0.70%
0.76%
Alger Small Cap Growth Institutional
Fund(c)
0.81%
0.75%
 
0.81%
 
(a)  Tier 1 rate is paid on assets up to 2 billion, Tier 2 rate is paid on assets between 2 billion and 3 billion, Tier 3 rate is paid on assets between 3 billion and 4 billion, Tier 4 rate is paid on assets between  4 billion and  5 billion, and Tier 5 rate is paid on assets in excess of 5 billion.
(b)  Tier 1 rate is paid on all assets.
(c)  Tier 1 rate is paid on assets up to 1 billion and Tier 2 rate is paid on assets in excess of 1 billion.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Alger Management has contractually agreed to waive fees or to reimburse Fund expenses (excluding acquired fund fees and expenses, dividend expense on short sales, borrowing costs, interest, taxes, brokerage and extraordinary expenses) through February 29, 2024 to the extent necessary to limit the amount by which the total annual fund operating expenses exceed the rates, based on average daily net assets, as listed in the table below:
 
    CLASS    
FEES WAIVED
/ REIMBURSED
FOR THE SIX
MONTHS ENDED
 

    A

   

    I

    R

    Y

    Z

   
Z-2
    APRIL 30, 2022  
Alger Capital Appreciation
Institutional Fund
         
     
     
     
0.75%

   
     
0.85%

  $ 161,648  
Alger Focus Equity Fund
         
     
     
     
0.58%

   
0.63%

   

    27,327  
Alger Mid Cap Growth
Institutional Fund
         
     
     
     
     
     
0.99%

    9,637  
Alger Small Cap Growth
Institutional Fund
         
     
     
     
     
     
0.99%

     
 
Alger Management may, during the term of the contract, recoup any fees waived or expenses reimbursed pursuant to the contract; however, a Fund will only make repayments to the Investment Manager if such repayment does not cause a Fund's expense ratio after the repayment is taken into account, to exceed both (i) the expense cap in place at the time such amounts were waived or reimbursed, and (ii) a Fund's current expense cap. Such recoupment is limited to two years from the date the amount is initially waived or reimbursed. For the six months ended April 30, 2022, there were no recoupments made to the Investment Manager.
 
(b)   Administration Fees: Fees incurred by each Fund, pursuant to the provisions of the Trust's Fund Administration Agreement with Alger Management, are payable monthly and computed based on the average daily net assets of each Fund at the annual rate of 0.0275%.
 
(c)    Distribution Fees: Class A Shares: The Trust has adopted a Distribution Plan pursuant to which Class A shares of Alger Focus Equity Fund pay Fred Alger & Company, LLC, the Trust's distributor and an affiliate of the Investment Manager (the "Distributor" or "Alger LLC") a fee at the annual rate of 0.25% of the respective average daily net assets of the Class A shares of the Fund to compensate Alger LLC for its activities and expenses incurred in distributing and/or administering the share class and/or shareholder servicing. The fees paid may be more or less than the expenses incurred by Alger LLC.
 
Class C Shares: The Trust has adopted a Distribution Plan pursuant to which Class C shares of Alger Focus Equity Fund pays Alger LLC a fee at the annual rate of 1% of the average daily net assets of the Class C shares of the Fund to compensate Alger LLC for its activities and expenses incurred in distributing and/or servicing the Class C shares. The fees paid may be more or less than the expenses incurred by Alger LLC.
 
Class R Shares: The Trust has adopted a Distribution Plan pursuant to which Class R shares of  each Fund issuing such shares pays Alger LLC a fee at the annual rate of  0.50% of  the respective average daily net assets of the Class R shares of the designated Fund to compensate Alger LLC for its activities and expenses incurred in distributing and/or servicing the Class R shares. The fees paid may be more or less than the expenses incurred by the Distributor.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
 
(d)   Sales Charges: Sales of shares of the Funds may be subject to contingent deferred sales charges. The contingent deferred sales charges are used by Alger LLC to offset distribution expenses previously incurred. Sales charges do not represent expenses of the Trust. For the six months ended April 30, 2022, contingent deferred sales charges imposed, all of which were retained by Alger LLC, were as follows:
 

   
 CONTINGENT
DEFERRED SALES
CHARGES
 
 Alger Focus Equity Fund  
 
$
2,355
 




 
(e)   Brokerage Commissions: During the six months ended April 30, 2022, Alger Capital Appreciation Institutional Fund, Alger Focus Equity Fund, Alger Mid Cap Growth Institutional Fund and Alger Small Cap Growth Institutional Fund paid Alger LLC commissions of $173,131, $51,007, $21,889 and $13,912, respectively, in connection with securities transactions.
 
(f)    Shareholder Administrative Fees: The Trust has entered into a Shareholder Administrative Services Agreement with Alger Management to compensate Alger Management for its liaising with, providing administrative oversight of, the Trust’s transfer agent, and for other related services. The Funds compensate Alger Management at the annual rate of 0.0165% of their respective average daily net assets for the Class A and Class C shares and 0.01% of their respective average daily net assets for the Class I, Class R, Class Y, Class Z and Class Z-2 shares for these services.
 
Alger Management makes payments to intermediaries that provide sub-accounting services to omnibus accounts invested in the Funds. A portion of the fees paid by Alger Management to intermediaries that provide sub-accounting services are charged back to the appropriate Fund, subject to certain limitations, as approved by the Board. For the six months ended April 30, 2022, Alger Management charged back to Alger Capital Appreciation Institutional Fund, Alger Focus Equity Fund, Alger Mid Cap Growth Institutional Fund, and Alger Small Cap Growth Institutional Fund, $884,123, $53,443, $31,618 and $56,426, respectively, for these services, which are included in the transfer agent fees in the accompanying Statements of Operations.
 
(g)    Trustee Fees: Each trustee who is not an "interested person" of the Trust, as defined in the 1940 Act (“Independent Trustee”), receives a fee of $156,000 per annum, paid pro rata based on net assets by each fund in the Alger Fund Complex, plus travel expenses incurred for attending board meetings. The term "Alger Fund Complex" refers to the Trust, The Alger Funds, The Alger Funds II, The Alger Portfolios, Alger Global Focus Fund and The Alger ETF Trust, each of which is a registered investment company managed by Alger Management. The Independent Trustee appointed as Chairman of the Board receives additional compensation of $22,000 per annum paid pro rata based on net assets by each fund in the Alger Fund Complex. Additionally, each member of the Audit Committee receives a fee of $13,000 per annum, paid pro rata based on net assets by each fund in the Alger Fund Complex.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
 
Effective January 1, 2022, the Board adopted a policy requiring Trustees to receive a minimum of 10% of their annual compensation in shares of one or more of the funds in the Alger Fund Complex.
 
Prior to January 1, 2022, each Independent Trustee received a fee of $142,000 per annum, paid pro rata based on net assets by each fund in the Alger Fund Complex, plus travel expenses incurred for attending board meetings. The Independent Trustee appointed as Chairman of  the Board received additional compensation of  $20,000 per annum paid  pro rata based on net assets by each fund in the Alger Fund Complex. Additionally, each member of the Audit Committee received a fee of $13,000 per annum, paid pro rata based on net assets by each fund in the Alger Fund Complex.
 
(h)    Interfund Trades: The Funds may engage in purchase and sale transactions with other funds advised by Alger Management or Weatherbie Capital, LLC, an affiliate of Alger Management. For the six months ended April 30, 2022, these purchases and sales were as follows:

 
 
PURCHASES
    SALES     REALIZED GAIN/LOSS
 
 Alger Small Cap Growth Institutional Fund 
 
$
1,695,466
    $     $  
 
(i)     Interfund Loans: The Funds, along with other funds in the Alger Fund Complex, may borrow money from and lend money to each other for temporary or emergency purposes. To the extent permitted under its investment restrictions, each Fund may lend uninvested cash in an amount up to 15% of its net assets to other funds in the Alger Fund Complex. If a Fund has borrowed from other funds in the Alger Fund Complex and has aggregate borrowings from all sources that exceed 10% of the Fund's total assets, such Fund will secure all of its loans from other funds in the Alger Fund Complex. The interest rate charged on interfund loans is equal to the average of the overnight time deposit rate and bank loan rate available to the Funds. There were no interfund loans outstanding as of April 30, 2022.
 
During the six months ended April 30, 2022, the Alger Capital Appreciation Institutional Fund, Alger Focus Equity Fund, Alger Mid Cap Growth Institutional Fund and Alger Small Cap Growth Institutional Fund incurred interfund loan interest expenses of $23,325, $85, $219, $639 respectively, which are included as interest expenses in the accompanying Statement of Operations.
 
(j)     Other Transactions with Afftliates: Certain officers and one Trustee of the Trust are directors and/or officers of Alger Management, the Distributor, or their affiliates. At April 30, 2022, Alger Management and its affiliated entities owned the following shares:

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

     
SHARE CLASS
 
      A

    Y

    Z

   
Z-2
 
Alger Capital Appreciation Institutional Fund
   
     
414
     
     
4,518
 
Alger Focus Equity Fund
   
14,581
     
408
     
38,745
     
 
Alger Mid Cap Growth Institutional Fund
   
     
     
     
4,909
 
Alger Small Cap Growth Institutional Fund
   
     
     
     
7,733
 

(k)     Shareholder Servicing Fees: The Trust has entered into a shareholder servicing agreement with Alger LLC whereby Alger LLC provides Class I and Class R shares of the applicable Funds with ongoing servicing of shareholder accounts. As compensation for such services, the Class I and Class R shares of each applicable Fund pay Alger LLC a monthly fee at an annual rate of 0.25% of the value of the average daily net assets of those classes. The fees paid may be more or less than the expenses incurred by the Distributor.
 
NOTE 4 — Securities Transactions:

The following summarizes the securities transactions by each Fund, other than U.S. Government securities, in-kind transactions and short-term securities, for the six months ended April 30, 2022:
 
   
PURCHASES
   
SALES
 
Alger Capital Appreciation Institutional Fund
 
$
2,117,298,448
   
$
2,486,856,847
 
Alger Focus Equity Fund
   
932,749,374
     
979,898,387
 
Alger Mid Cap Growth Institutional Fund
   
117,347,022
     
128,298,666
 
Alger Small Cap Growth Institutional Fund
   
30,410,991
     
58,832,619
 
 
NOTE 5 — Borrowing:
 
The Funds may borrow from Brown Brothers Harriman & Co., the Funds' custodian (the "Custodian" or "BBH"), on an uncommitted basis. Each Fund pays the Custodian a market rate of interest, generally based upon a rate of return with respect to each respective currency borrowed, taking into consideration relevant overnight and short-term reference rates and the range of distribution between and among the interest rates paid on deposits to other institutions, less applicable commissions, if any. Borrowings from the Custodian are included in Bank overdrafts in the Statements of Assets and Liabilities. The Funds may also borrow from other funds in the Alger Fund Complex, as discussed in Note 3(i). For the six months ended April 30, 2022, the Funds had the following borrowings from the Custodian and other funds in the Alger Fund Complex:

   
AVERAGE DAILY
BORROWING
   
WEIGHTED AVERAGE
INTEREST RATE
 
Alger Capital Appreciation Institutional Fund
 
$
5,452,561
     
1.30
%
Alger Focus Equity Fund
   
18,809
     
1.17
 
Alger Mid Cap Growth Institutional Fund
   
111,593
     
1.72
 
Alger Small Cap Growth Institutional Fund
   
125,559
     
1.05
 

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

The highest amount borrowed from the Custodian and other funds in the Alger Fund Complex during the six months ended April 30, 2022 by each Fund was as follows:
 
    HIGHEST BORROWING  
Alger Capital Appreciation Institutional Fund
 
$
124,304,000
 
Alger Focus Equity Fund
   
2,974,000
 
Alger Mid Cap Growth Institutional Fund
   
3,294,539
 
Alger Small Cap Growth Institutional Fund
   
2,759,858
 

On September 7, 2021, BBH, the Fund's custodian, announced that it had entered into   an agreement with State Street Bank and Trust Company ("State Street") to sell BBH's Investor Services business to State Street (the “Transaction”). The completion of the Transaction is subject to customary closing conditions and regulatory approvals. As a result of the Transaction, it is expected that State Street will replace BBH as the Fund's custodian effective as of the completion of the Transaction, the timing of which is not currently finalized.
 
NOTE 6 — Share Capital:
 
The Trust has an unlimited number of authorized shares of beneficial interest of  $.001 par value which are presently divided into four series. Each series is divided into separate classes. During the six months ended April 30, 2022, and the year ended October 30, 2021, transactions of shares of beneficial interest were as follows:

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

     
FOR THE SIX MONTHS ENDED APRIL 30, 2022
     
FOR THE YEAR ENDED
OCTOBER 31, 2021
 
     
SHARES
     
AMOUNT
      SHARES
     
AMOUNT
 
Alger Capital Appreciation Institutional Fund                                
Class I:
                               
Shares sold
   
3,324,189
   
$
125,842,317
      6,932,849
    $ 308,319,220  
Dividends reinvested
   
8,729,064
     
357,978,918
      7,958,967       329,262,481  
Shares redeemed
   
(7,216,445
)
   
(278,014,076
)
    (17,543,284 )     (777,044,318 )
Net increase (decrease)
   
4,836,808
   
$
205,807,159
      (2,651,468 )   $ (139,462,617 )
Class R:
                               
Shares sold
   
755,718
   
$
22,604,378
      1,177,042
    $ 44,215,802  
Dividends reinvested
   
3,173,301
     
103,957,327
      2,698,455       93,258,631  
Shares redeemed
   
(1,994,895
)
   
(61,764,602
)
    (4,640,710 )     (175,648,393 )
Net increase (decrease)
   
1,934,124
   
$
64,797,103
      (765,213 )   $ (38,173,960 )
Class Y:
                               
Shares sold
   
2,224,452
   
$
92,072,069
     
3,730,299
   
$
170,087,788
 
Dividends reinvested
   
2,290,601
     
96,686,254
     
1,699,103
     
71,753,136
 
Shares redeemed
   
(4,633,243
)
   
(193,094,222
)
   
(3,243,335
)
   
(149,405,709
)
Net increase (decrease)
   
(118,190
)
 
$
(4,335,899
)
   
2,186,067
   
$
92,435,215
 
Class Z-2:
                               
Shares sold
   
1,076,963
   
$
41,898,762
     
1,841,479
    $ 84,954,469  
Dividends reinvested
   
2,335,207
     
98,265,521
     
1,986,371
      83,705,657  
Shares redeemed
   
(2,980,284
)
   
(114,988,485
)
   
(3,630,137
)
    (165,261,002 )
Net increase
   
431,886
   
$
25,175,798
     
197,713
    $ 3,399,124  

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
FOR THE SIX MONTHS ENDED APRIL 30, 2022
     
FOR THE YEAR ENDED OCTOBER 31, 2021
 

 
SHARES
     
AMOUNT
     
SHARES
     
AMOUNT
 
 Alger Capital Appreciation Institutional Fund                              
Class A:
                             
Shares sold
   
189,464
   
$
10,154,612
     
525,001
   
$
30,364,913
 
Shares converted from Class C
   
28,053
     
1,470,808
     
43,235
     
2,591,544
 
Dividends reinvested
   
250,005
     
14,062,788
     
101,841
     
5,447,453
 
Shares redeemed
   
(339,969
)
   
(17,986,148
)
   
(601,268
)
   
(34,069,982
)
Net increase
   
127,553
   
$
7,702,060
     
68,809
   
$
4,333,928
 
Class C:
                               
Shares sold
   
156,042
   
$
7,491,383
     
190,103
   
$
10,358,874
 
Shares converted to Class A
   
(30,581
)
   
(1,470,808
)
   
(46,498
)
   
(2,591,544
)
Dividends reinvested
   
174,899
     
9,009,061
     
79,104
     
3,948,864
 
Shares redeemed
   
(146,488
)
   
(7,045,945
)
   
(250,063
)
   
(13,450,785
)
Net increase (decrease)
   
153,872
   
$
7,983,691
     
(27,354
)
 
$
(1,734,591
)
Class I:
                               
Shares sold
   
139,131
   
$
7,536,383
     
389,234
   
$
22,473,460
 
Subscriptions in-kind*
   
2,177,233
     
147,434,796
     
     
 
Dividends reinvested
   
152,486
     
8,642,907
     
75,865
     
4,083,795
 
Redemptions in-kind**
   
(2,223,483
)
   
(150,943,812
)
   
     
 
Shares redeemed
   
(262,249
)
   
(13,725,988
)
   
(522,965
)
   
(29,204,622
)
Net decrease
   
(16,882
)
 
$
(1,055,714
)
   
(57,866
)
 
$
(2,647,367
)
Class Y:
                               
Shares sold
   
392,300
   
$
21,949,839
     
824,636
   
$
47,977,736
 
Dividends reinvested
   
379,807
     
22,142,762
     
145,885
     
8,025,161
 
Shares redeemed
   
(267,637
)
   
(14,755,254
)
   
(402,682
)
   
(24,278,303
)
Net increase
   
504,470
   
$
29,337,347
     
567,839
   
$
31,724,594
 
Class Z:
                               
Shares sold
   
3,083,321
   
$
168,992,289
     
5,731,504
   
$
340,685,196
 
Dividends reinvested
   
2,426,793
     
141,093,762
     
914,460
     
50,203,839
 
Shares redeemed
   
(3,423,014
)
   
(181,727,688
)
   
(3,566,328
)
   
(210,194,962
)
Net increase
   
2,087,100
   
$
128,358,363
     
3,079,636
   
$
180,694,073
 

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
FOR THE SIX MONTHS ENDED APRIL 30, 2022
   
FOR THE YEAR ENDED OCTOBER 31, 2021
 
   
SHARES
   
AMOUNT
   
SHARES
   
AMOUNT
 
Alger Mid Cap Growth Institutional Fund
                       
Class I:
                       
Shares sold
   
185,412
   
$
5,008,415
     
482,262
   
$
22,388,935
 
Dividends reinvested
   
1,306,957
     
32,739,262
     
265,104
     
11,365,021
 
Shares redeemed
   
(464,297
)
   
(11,442,234
)
   
(1,198,853
)
   
(56,354,630
)
Net increase (decrease)
   
1,028,072
   
$
26,305,443
     
(451,487
)
 
$
(22,600,674
)
Class R:
                               
Shares sold
   
30,929
   
$
555,920
     
45,297
   
$
1,843,906
 
Dividends reinvested
   
166,142
     
3,214,840
     
21,723
     
816,986
 
Shares redeemed
   
(32,973
)
   
(625,934
)
   
(68,568
)
   
(2,755,560
)
Net increase (decrease)
   
164,098
   
$
3,144,826
     
(1,548
)
 
$
(94,668
)
Class Z-2:
                               
Shares sold
   
259,648
   
$
6,751,583
     
129,431
   
$
6,238,420
 
Dividends reinvested
   
353,527
     
9,138,654
     
45,688
     
1,987,879
 
Shares redeemed
   
(290,957
)
   
(6,983,495
)
   
(108,129
)
   
(4,941,876
)
Net increase
   
322,218
   
$
8,906,742
     
66,990
   
$
3,284,423
 

Alger Small Cap Growth Institutional Fund
                       
Class I:
                       
Shares sold
   
568,479
   
$
12,467,446
     
2,648,139
   
$
81,047,723
 
Dividends reinvested
   
1,270,807
     
28,224,632
     
314,052
     
9,029,003
 
Shares redeemed
   
(1,847,780
)
   
(40,774,966
)
   
(3,165,178
)
   
(96,910,193
)
Net decrease
   
(8,494
)
 
$
(82,888
)
   
(202,987
)
 
$
(6,833,467
)
Class R:
                               
Shares sold
   
46,270
   
$
693,792
     
110,776
   
$
2,554,915
 
Dividends reinvested
   
136,909
     
2,122,088
     
33,491
     
732,104
 
Shares redeemed
   
(70,023
)
   
(1,058,542
)
   
(236,982
)
   
(5,506,915
)
Net increase (decrease)
   
113,156
   
$
1,757,338
     
(92,715
)
 
$
(2,219,896
)
Class Z-2:
                               
Shares sold
   
2,061,901
   
$
44,729,050
     
3,681,090
   
$
115,278,838
 
Dividends reinvested
   
1,144,418
     
25,955,396
     
213,917
     
6,235,667
 
Shares redeemed
   
(2,496,003
)
   
(56,010,290
)
   
(2,414,400
)
   
(74,907,265
)
Net increase
   
710,316
   
$
14,674,156
     
1,480,607
   
$
46,607,240
 

* Certain shareholders of  the Fund subscribed shares in-kind.
 
** Certain shareholders of  the Fund redeemed shares in-kind.
 
Subscriptions In-Kind: The Fund may receive payment for Fund shares purchased wholly or in part by receiving portfolio securities from shareholders. For the six months ended April 30, 2022, the Fund had subscriptions in-kind in the amount of $147,434,796.
 
Redemptions In-Kind: The Fund may make payment for Fund shares redeemed wholly or in part by receiving portfolio securities from shareholders. For the six months ended April 30, 2022, the Fund had redemptions in-kind with total proceeds in the amount of $150,943,812. The net realized gains on these redemptions in-kind amounted to $77,070,975, which are not considered taxable for federal income tax purposes.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

NOTE 7 — Income Tax Information

At October 31, 2021, the Funds had no capital loss carryforwards utilized for federal income tax purposes.
 
The difference between book-basis and tax-basis unrealized appreciation (depreciation) is determined annually and is attributable primarily to the tax deferral of losses on wash sales, U.S. Internal Revenue Code Section 988 currency transactions, nondeductible expenses on dividends sold short, tax treatment of partnership investments, realization of unrealized appreciation of passive foreign investment companies, and return of capital from real estate investment trust investments.
 
The Funds accrue tax on unrealized gains in foreign jurisdictions that impose a foreign capital tax.
 
NOTE 8 — Fair Value Measurements:

The following is a summary of the inputs used as of April 30, 2022, in valuing the Funds’ investments carried at fair value on a recurring basis. Based upon the nature, characteristics, and risks associated with their investments, the Funds have determined that presenting them by security type and sector is appropriate.

Alger Capital Appreciation Institutional Fund        
  TOTAL    
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Communication Services
  $ 200,640,761    
$
200,640,761
   
$
   
$
 
Consumer Discretionary
    547,003,343      
521,929,890
     
23,870,720
     
1,202,733
 
Consumer Staples
    11,125,709      
11,125,709
     
     
 
Energy
    67,921,922      
67,921,922
     
     
 
Financials
    87,098,835      
87,098,835
     
     
 
Healthcare
    406,813,690      
364,873,106
     
41,940,584
     
 
Industrials
    226,022,299      
226,022,299
     
     
 
Information Technology
    1,164,473,736      
1,164,473,736
     
     
 
Materials
    28,152,541      
28,152,541
     
     
 
Utilities
    9,163,498      
9,163,498
     
     
 
TOTAL COMMON STOCKS
  $ 2,748,416,334    
$
2,681,402,297
   
$
65,811,304
   
$
1,202,733
 
PREFERRED STOCKS
                               
Information Technology
    2,315,291      
     
     
2,315,291
 
REAL ESTATE INVESTMENT TRUST
                               
Real Estate
    9,828,169      
9,828,169
     
     
 
SPECIAL PURPOSE VEHICLE
                               
Information Technology
    4,293,561      
     
     
4,293,561
 
TOTAL INVESTMENTS IN SECURITIES
  $ 2,764,853,355    
$
2,691,230,466
   
$
65,811,304
   
$
7,811,585
 

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Alger Focus Equity Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Communication Services
 
$
91,955,120
   
$
91,955,120
   
$
   
$
 
Consumer Discretionary
   
238,716,751
     
238,716,751
     
     
 
Energy
   
26,775,197
     
26,775,197
     
     
 
Financials
   
56,245,047
     
56,245,047
     
     
 
Healthcare
   
138,605,888
     
115,464,203
     
23,141,685
     
 
Industrials
   
84,912,631
     
84,912,631
     
     
 
Information Technology
   
493,568,241
     
493,568,241
     
     
 
Materials
   
3,732,627
     
3,732,627
     
     
 
TOTAL COMMON STOCKS
 
$
1,134,511,502
   
$
1,111,369,817
   
$
23,141,685
   
$
 
PREFERRED STOCKS
                               
Healthcare
   
*
   
     
     
*
TOTAL INVESTMENTS IN SECURITIES
 
$
1,134,511,502
   
$
1,111,369,817
   
$
23,141,685
   
$
 

Alger Mid Cap Growth Institutional Fund          
  TOTAL    
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Communication Services
    3,371,598      
3,371,598
     
     
 
Consumer Discretionary
    9,768,559      
9,199,412
     
569,147
     
 
Consumer Staples
    343,758      
343,758
     
     
 
Energy
    5,743,078      
5,743,078
     
     
 
Financials
    3,033,760      
3,033,760
     
     
 
Healthcare
    11,484,320      
11,484,320
     
     
 
Industrials
    8,072,289      
8,072,289
     
     
 
Information Technology
    20,117,886      
20,117,886
     
     
 
Materials
    1,111,110      
1,111,110
     
     
 
Utilities
    1,842,440      
1,842,440
     
     
 
TOTAL COMMON STOCKS
  $ 64,888,798    
$
64,319,651
   
$
569,147
   
$
 
PREFERRED STOCKS
                               
Healthcare
RIGHTS
    *    
     
     
*
Healthcare
    304,508      
     
     
304,508
 
REAL ESTATE INVESTMENT TRUST
                               
Real Estate
    370,976      
370,976
     
     
 
SPECIAL PURPOSE VEHICLE
                               
Information Technology
    1,094,879      
     
     
1,094,879
 
TOTAL INVESTMENTS IN SECURITIES
  $ 66,659,161    
$
64,690,627
   
$
569,147
   
$
1,399,387
 

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Alger Small Cap Growth Institutional Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Communication Services
  $ 11,435,120    
$
11,435,120
   
$
    $  
Consumer Discretionary
    23,776,061      
23,776,061
     
       
Consumer Staples
    10,795,771      
10,795,771
     
       
Energy
    12,089,986      
12,089,986
     
       
Financials
    2,229,719      
2,229,719
     
       
Healthcare
    59,480,038      
57,723,098
     
      1,756,940  
Industrials
    11,985,240      
11,985,240
     
       
Information Technology
    52,571,363      
52,571,363
     
       
Materials
    5,047,496      
5,047,496
     
       
TOTAL COMMON STOCKS
  $ 189,410,794    
$
187,653,854
   
$
    $ 1,756,940  
PREFERRED STOCKS
                               
Healthcare
    *    
     
      *
Information Technology
    6,805,597      
     
      6,805,597  
TOTAL PREFERRED STOCKS
  $ 6,805,597    
$
   
$
    $ 6,805,597  
RIGHTS
                               
Healthcare
    380,562      
     
      380,562  
REAL ESTATE INVESTMENT TRUST
                               
Real Estate
    2,029,702      
2,029,702
     
       
SPECIAL PURPOSE VEHICLE
                               
Information Technology
    2,252,482      
     
      2,252,482  
TOTAL INVESTMENTS IN SECURITIES
  $ 200,879,137    
$
189,683,556
   
$
    $ 11,195,581  

* Prosetta Biosciences, Inc., Series D shares are classified as a Level 3 investment and are fair valued at zero as of April 30, 2022.

   
 FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Capital Appreciation Institutional Fund
 
Common Stocks
 

     
Opening balance at November 1, 2021
 
$
1,339,796
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(137,063
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
1,202,733
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
 
$
(137,063
)

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


 
 FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Capital Appreciation Institutional Fund
 
Preferred Stocks
 
Opening balance at November 1, 2021
 
$
2,688,128
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(372,837
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
2,315,291
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
 
$
(372,837
)

   
 FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Capital Appreciation Institutional Fund
 
Special Purpose Vehicle
 
Opening balance at November 1, 2021
 
$
4,923,444
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(629,883
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
4,293,561
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
 
$
(629,883
)

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Focus Equity Fund
 
Preferred Stocks
 
Opening balance at November 1, 2021
 
$
0
**
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
0
**
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
 
$
 

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Mid Cap Growth Institutional Fund
 
Preferred Stocks
 

     
Opening balance at November 1, 2021
 
$
0
**
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
0
**
Net change in unrealized appreciation (depreciation) attributable to investments  still held at April 30, 2022*
 
$
 

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Mid Cap Growth Institutional Fund
 
Rights
 
Opening balance at November 1, 2021
 
$
317,196
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(12,688
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
304,508
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
 
$
(12,688
)

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Mid Cap Growth Institutional Fund
 
Special Purpose Vehicle
 
Opening balance at November 1, 2021
  $    
Transfers into Level 3
   
1,260,209
 
Transfers out of Level 3
   
 
Total gains or losses
   
 
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(165,330
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
1,094,879
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
 
$
(165,330
)

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Small Cap Growth Institutional Fund
 
Common Stocks
 
Opening balance at November 1, 2021
 
$
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
1,756,940
 
Sales
   
 
Closing balance at April 30, 2022
   
1,756,940
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
  $  

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Small Cap Growth Institutional Fund
 
Preferred Stocks
 
Opening balance at November 1, 2021
 
$
7,901,516
**
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(1,095,919
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
6,805,597
**
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
 
$
(1,095,919
)

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Small Cap Growth Institutional Fund
 
Rights
 
Opening balance at November 1, 2021
 
$
396,419
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(15,857
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
380,562
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
 
$
(15,857
)

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Small Cap Growth Institutional Fund
 
Special Purpose
Vehicle
 
Opening balance at November 1, 2021
 
$
2,589,729
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(337,247
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
2,252,482
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
 
$
(337,247
)

* Net change in unrealized appreciation (depreciation) is included in net change in unrealized appreciation (depreciation) on investments in the accompanying statements of operations.
** Prosetta Biosciences, Inc., Series D shares are classifted as a Level 3 investment and are fair valued at zero as of April 30, 2022.
 
The following table provides quantitative information about each Fund's Level 3 fair value measurements of its investments as of April 30, 2022. The table below is not intended to be all-inclusive, but rather provides information on the Level 3 inputs as they relate to each Fund’s fair value measurements.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
   
Fair Value
April 30, 2022
 
Valuation
Methodology
Unobservable
Input
 
Input/Range
   
Weighted Average
Inputs
 
Alger Small Cap Growth Institutional Fund          
 
Common Stocks
 
$
1,202,733
 
Income
Approach
Discount Rate
Probability of Success
   
0.00%-4.70
15.00%-50.00
%
%
   
N/A
 
Preferred Stocks
   
2,315,291
 
Market
Approach
Transaction Price
Revenue Multiple
   
N/A
26.0x-30.57
x
    N/A
 
Special Purpose Vehicle
   
4,293,561
 
Market
Approach
Transaction Price
Revenue Multiple
   
N/A
26.0x-30.57
x
    N/A
 
                             
Alger Focus Equity Fund
                           
Preferred Stocks
 
$
*
Income
 Approach
Discount Rate
    100.00
%
   
N/A
 
                             
Alger Mid Cap Growth Institutional Fund
 
Preferred Stocks
 
$
*
Income
Approach
Discount Rate
   
100.00
%
   
N/A
 
Rights
   
304,508
 
Income
Approach
Discount Rate
Probability of Success
   
5.67%-6.01
0.00%-60.00
%
%
   
N/A
 
Special Purpose Vehicle
   
1,094,879
 
Market
Approach
Transaction Price
Revenue Multiple
   
N/A
26.0x-30.57
x
   
N/A
 
                             
Alger Small Cap Growth Institutional Fund
 
 
Common Stocks
 
$
1,756,940
 
 Market
Approach
 
Priced at Cost
   
N/A
         
Preferred Stocks
   
*
Income
Approach
Discount Rate
   
100.00
%
   
N/A
 
 
Preferred Stocks
   
6,805,597
 
 Market
Approach
 
Transaction Price
Revenue Multiple
   
N/A
26.0x-30.57
x
       
Rights
   
380,562
 
Income
Approach
Discount Rate Probability of Success
   
5.67%-6.01
0.00%-60.00
%
%
   
N/A
 
Special Purpose Vehicle
   
2,252,482
 
Market
Approach
Transaction Price
Revenue Multiple
   
N/A
26.0x-30.57
x
   
N/A
 

*
Prosetta Biosciences, Inc., Series D shares are classifted as a Level 3 investment and are fair valued at zero as of April 30, 2022.

The significant unobservable inputs used in the fair value measurement of the Fund's securities are revenue and EBITDA multiples, discount rates, and the probability of success of certain outcomes. Significant increases and decreases in these inputs in isolation and interrelationships between these inputs would have resulted in significantly higher or lower fair value measurements than those noted in the table above. Generally, all other things being equal, increases in revenue and EBITDA multiples, decreases in discount rates, and increases in the probability of success result in higher fair value measurements, whereas decreases in revenues and EBITDA multiples, increases in discount rates, and decreases in the probability of success result in lower fair value measurements.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
Certain of the Funds’ assets and liabilities are held at carrying amount or face value, which approximates fair value for financial statements purposes. As of April 30, 2022, such assets were categorized within the ASC 820 disclosure hierarchy as follows:
 
   
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
Cash, Foreign Cash and Cash Equivalents:
                       
Alger Capital Appreciation Institutional Fund
 
$
34,974,081
   
$
319,381
   
$
34,654,700
   
$
 
Alger Focus Equity Fund
   
76,515,826
     
     
76,515,826
     
 
Alger Mid Cap Growth Institutional Fund
   
1,517,870
     
     
1,517,870
     
 
Alger Small Cap Growth Institutional Fund
   
2,510,277
     
     
2,510,277
     
 

NOTE 9 — Derivatives:          

FASB Accounting Standards Codification 815 - Derivatives and Hedging ("ASC 815") requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.
 
Options — The Funds seek to capture the majority of the returns associated with equity market investments. To meet this investment goal, the Funds invest in a broadly diversified portfolio of common stocks, the Funds may also buy and sell call and put options on equities and equity indexes. The Funds may also purchase call options to increase their exposure to the stock market and also provide diversification of risk. The Funds may also purchase put options in order to protect from significant market declines that may occur over a short period of time. The Funds may also write covered call and cash secured put options to generate cash flows while reducing the volatility of the Funds' portfolios. The cash flows may be an important source of the Funds’ returns, although written call options may reduce the Funds' ability to profit from increases in the value of the underlying security or equity portfolio. The value of a call option generally increases as the price of the underlying stock increases and decreases as the stock decreases in price. Conversely, the value of a put option generally increases as the price of the underlying stock decreases and decreases as the stock increases in price. The combination of the diversified stock portfolio and the purchase and sale of options is intended to provide the Funds with the majority of the returns associated with equity market investments but with reduced volatility and returns that are augmented with the cash flows from the sale of options.
 
The Funds’ option contracts were not subject to any rights of offset with any counterparty. All of the Funds' options were exchange traded which utilize a clearinghouse that acts as an intermediary between buyer and seller, receiving initial and maintenance margin from both, and guaranteeing performance of the option contract.
 
There were no derivative instruments held by the Funds throughout the six months ended or as of April 30, 2022.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
NOTE 10 — Principal Risks:          

Alger Capital Appreciation Institutional Fund — Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility.
 
Alger Focus Equity Fund - Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious  diseases  and similar public health threats, recessions, or other events could have a significant impact   on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of  assets may be invested    in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. Assets may be focused in a small number of  holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment.
 
Alger Mid Cap Growth Institutional Fund — Investing in the stock market involves   risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Investing in companies of medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
Alger Small Cap Growth Institutional Fund — Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Investing in companies of small and medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. At times, the Portfolio may hold a large cash position, which may underperform relative to equity securities.
 
Transactions in foreign securities may involve certain considerations and risks not typically associated with those of U.S. companies because of, among other factors, the level of governmental supervision and regulation of  foreign security markets, and the possibility  of political or economic instability. Additional risks associated with investing in emerging markets include increased volatility, limited liquidity, and less stringent regulatory and legal systems.
 
NOTE 11 - Affiliated Securities:          

 
The issuers of the securities listed below are deemed to be affiliates of the Funds because the Funds and their affiliates, collectively, owned 5% or more of the issuer's voting securities during all or part of the six months ended April 30, 2022. Information regarding the Funds' holdings of such securities is set forth in the following table:

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
 Security  
Value at
October 31,
2021
   
Purchases/
Conversion
   
Sales/
Conversion
   
Dividend/
Interest
Income
   
Realized
Gain (Loss)
   
Net Increase (Decrease)
in
Unrealized
App(Dep)
   
Value at
April 30,
2022
 
Alger Capital Appreciation Institutional Fund Special Purpose Vehicle
                                   
Crosslink Ventures Capital LLC,
                                         
Cl. A
 
$
4,923,444
    $ -    
$
-
    $ -     $ -     $ (629,883 )  
$
4,293,561
 
Total
 
$
4,923,444
    $ -    
$
-
    $ -     $ -     $ (629,883 )  
$
4,293,561
 


 
Security
 
Value at
October 31,
2021
   
Purchases/
Conversion
   
Sales/
Conversion
   
Dividend/
Interest
Income
   
Realized
Gain (Loss)
   
Net Increase (Decrease)
in
Unrealized
App(Dep)
   
Value at
April 30,
2022
 
Alger Focus Equity Fund
                                         
Preferred Stocks
                                         
Prosetta Biosciences, Inc., Series D
 
$
-
*
 
$
   
$
   
$
   
$
   
$
   
$
-
*
Total
 
$
-
*
 
$
   
$
   
$
   
$
   
$
   
$
-
*

 
Security
 
Value at
October 31,
2021
   
Purchases/
Conversion
   
Sales/
Conversion
   
Dividend/
Interest
Income
   
Realized
Gain (Loss)
   
Net  Increase (Decrease)
in
Unrealized
App(Dep)
   
Value at
April 30,
2022
 
Alger Mid Cap Growth Institutional Fund
 
Preferred Stocks
                                         
Prosetta Biosciences, Inc., Series D
 
$
-
*
 
$
   
$
   
$
   
$
   
$
   
$
-
*
Special Purpose Vehicle
                                                       
Crosslink Ventures Capital LLC, Cl. A
   
880,616
     
     
     
     
     
(112,662
)
   
767,954
 
Crosslink Ventures Capital LLC, Cl. B
   
379,593
     
     
     
     
     
(52,668
)
   
326,925
 
Total
 
$
1,260,209
   
$
   
$
   
$
   
$
   
$
(165,330
)
 
$
1,094,879
 

 
Security
 
Value at
October 31,
2021
   
Purchases/
Conversion
   
Sales/
Conversion
   
Dividend/
Interest
Income
   
Realized
Gain (Loss)
   
Net  Increase (Decrease)
in
Unrealized
App(Dep)
   
Value at
April 30,
2022
 
Alger Small Cap Growth Institutional Fund
 
Preferred Stocks
                                         
Prosetta Biosciences, Inc., Series D
 
$
*
 
$
   
$
   
$
   
$
   
$
   
$
-
*
Special Purpose Vehicle
                                                       
Crosslink Ventures Capital LLC, Cl. A
   
2,041,428
     
     
     
     
     
(261,171
)
   
1,780,257
 
Crosslink Ventures Capital LLC, Cl. B
   
548,301
     
     
     
     
     
(76,076
)
   
472,225
 
Total
 
$
2,589,729
   
$
   
$
   
$
   
$
   
$
(337,247
)
 
$
2,252,482
 

*
Prosetta Biosciences, Inc., Series D shares are classifted as a Level 3 investment and are fair valued at zero as of April 30, 2022.

THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
NOTE 12 — Subsequent Events:          

Management of each Fund has evaluated events that have occurred subsequent to April 30, 2022, through the issuance date of the Financial Statements. No such events have been identified which require recognition and/or disclosure.

ADDITIONAL INFORMATION (Unaudited)


Shareholder Expense Example          

As a shareholder of a Fund, you incur two types of costs: transaction costs, if applicable, including sales charges (loads) and redemption fees; and ongoing costs, including management fees, distribution (12b-1) fees, if applicable, and other Fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of  investing   in a Fund and to compare these costs with the ongoing costs of investing in other mutual funds.
 
The example below is based on an investment of $1,000 invested at the beginning of the six-month period starting November 1, 2021 and ending April 30, 2022 and held for the entire period.
 
Actual Expenses          

The first line for each class of shares in the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled "Expenses Paid During the Six Months Ended April 30, 2022" to estimate the expenses you paid on your account during this period.
 
Hypothetical Example for Comparison Purposes          

The second line for each class of shares in the table below provides information about hypothetical account values and hypothetical expenses based on the actual expense ratio for each class of the Fund’s shares and an assumed rate of return of 5% per year before expenses, which is not the Fund's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.
 
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs, such as sales charges (loads) and redemption fees. Therefore, the second line under each class of shares in the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)


   
Beginning
Account
Value
November 1, 2021
Ending
Account
Value
April 30, 2022
Expenses
Paid During
the Six Months
Ended
April 30, 2022(a)
Annualized Expense Ratio For the
Six Months Ended
April 30, 2022(b)
Alger Capital Appreciation Institutional Fund        
Class I
Actual
$ 1,000.00
$          733.50
$ 4.94
1.15%
 
Hypothetical(c)
1,000.00
1,019.09
5.76
1.15
Class R
Actual
1,000.00
732.00
6.74
1.57
 
Hypothetical(c)
1,000.00
1,017.01
7.85
1.57
Class Y
Actual
1,000.00
735.10
3.23
0.75
 
Hypothetical(c)
1,000.00
1,021.08
3.76
0.75
Class Z-2
Actual
1,000.00
734.70
3.48
0.81
 
Hypothetical(c)
1,000.00
1,020.78
4.06
0.81
           
Alger Focus Equity Fund
       
Class A
Actual
$ 1,000.00
$          709.00
$ 3.98
0.94%
 
Hypothetical(c)
1,000.00
1,020.13
4.71
0.94
Class C
Actual
1,000.00
739.00
7.33
1.70
 
Hypothetical(c)
1,000.00
1,016.36
8.50
1.70
Class I
Actual
1,000.00
748.30
3.94
0.91
 
Hypothetical(c)
1,000.00
1,020.28
4.56
0.91
Class Y
Actual
1,000.00
749.60
2.52
0.58
 
Hypothetical(c)
1,000.00
1,021.92
2.91
0.58
Class Z
Actual
1,000.00
749.40
2.65
0.61
 
Hypothetical(c)
1,000.00
1,021.77
3.06
0.61
           
Alger Mid Cap Growth Institutional Fund
       
Class I         
  Actual
$ 1,000.00
$          652.60
$ 5.90
1.44%

 Hypothetical(c)
1,000.00
1,017.65
7.20
1.44
Class R        
  Actual
1,000.00
651.10
7.66
1.87

 Hypothetical(c)
1,000.00
1,015.52
9.35
1.87
Class Z-2 
  Actual
1,000.00
654.10
4.06
0.99

 Hypothetical(c)
1,000.00
1,019.89
4.96
0.99
           
Alger Small Cap Growth Institutional Fund
Class I
Actual
$ 1,000.00
$          650.10
$ 5.32
1.30%
 
Hypothetical(c)
1,000.00
1,018.35
6.51
1.30
Class R
Actual
1,000.00
648.90
6.99
1.71
 
Hypothetical(c)
1,000.00
1,016.31
8.55
1.71
Class Z-2
Actual
1,000.00
651.10
3.89
0.95
 
Hypothetical(c)
1,000.00
1,020.08
4.76
0.95
 
(a)
Expenses are equal to the annualized expense ratio of the respective share class, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period).
(b)
Annualized.
(c)
5% annual return before expenses.

THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)


Privacy Policy

U.S. Consumer Privacy Notice    Rev. 6/22/21
 
FACTS
 
WHAT DOES ALGER DO WITH YOUR PERSONAL INFORMATION?
 
Why?
 
Financial companies choose how they share your personal information. Federal law gives consumers the right to limit some but not all sharing. Federal law also requires us to tell you how we collect, share, and protect your personal information. Please read this notice carefully to understand what we do.
 
What?
 
The types of personal information we collect and share depend on the product or service you have with us. This information can include:
•          Social Security number and
•          Account balances and
•          Transaction history and
•          Purchase history and
•          Assets
When you are no longer our customer, we continue to share your information as described in this notice.
 
How?
 
All financial companies need to share personal information to run their everyday business. In the section below, we list the reasons financial  companies can share personal information; the reasons Alger chooses to share; and whether you can limit this sharing.
 

 
Reasons we can share your personal
information
 
Does
Alger share?
 
Can you limit
this sharing?
 
For our everyday business purposes — such as to process your transactions, maintain your account(s), respond to court orders and legal investigations, or report to credit bureaus
 
Yes
 
No
 
For our marketing purposes — to offer our products and services to you
 
Yes
 
No
 
For joint marketing with other financial
companies
 
No
 
We don’t share
 
For our affiliates' everyday business purposes — information about your transactions and experiences
 
Yes
 
No
 
For our affiliates' everyday business purposes — information about your creditworthiness
 
No
 
We don’t share
 
For nonafffiliates to market to you
 
No
 
We don’t share
 
Questions? Call 1-800-223-3810
       

THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)


 
Who we are
   
 
Who is providing this notice?
 
Alger includes Fred Alger Management, LLC and Fred Alger & Company, LLC as well as the following funds: The Alger Funds, The Alger Funds II, The Alger Institutional Funds, The Alger Portfolios, Alger Global Focus Fund, and The Alger ETF Trust.
 

 
What we do
   
 
How does Alger protect my personal information?
 
To protect your personal information from unauthorized access and use, we use security measures that comply with federal law. These measures include computer safeguards and secured files and buildings
 
How does Alger collect my personal information?
 
We collect your personal information, for example, when you:
•   Open an account or
•   Make deposits or withdrawals from your account or
•   Give us your contact information or
•   Provide account information or
   Pay us by check.

 
Why can’t I limit all sharing?
 
Federal law gives you the right to limit some but not all sharing related to:
•   sharing for affiliates' everyday business purposes -
information about your credit worthiness
•   affiliates from using your information to market to you
•   sharing for nonaffiliates to market to you
State laws and individual companies may give you additional rights to limit sharing.
 

 
Definitions
   
 
Affiliates
 
Companies related by common ownership or control.
They can be financial and nonfinancial companies
   Our affiliates include Fred Alger Management, LLC, Weatherbie Capital, LLC and Fred Alger & Company, LLC as well as the following funds: The Alger Funds, The Alger Funds II, The Alger Institutional Funds, The Alger Portfolios, Alger Global Focus Fund, and The Alger ETF Trust.
 
Nonaffiliates
 
Companies not related by common ownership or control They can be financial and nonfinancial companies.
 
Joint marketing
 
A formal agreement between nonaffiliated financial companies that together market financial products or services to you.

THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)

 
Proxy Voting Policies          

A description of the policies and procedures the Funds use to determine how to vote proxies relating to portfolio securities and the proxy voting record is available, without charge, by calling (800) 992-3863 or online on the Funds' website at http://www.alger.com or on the SEC's website at http://www.sec.gov.
 
Fund Holdings          

The Board has adopted policies and procedures relating to disclosure of the Funds’ portfolio securities. These policies and procedures recognize that there may be legitimate business reasons for holdings to be disclosed and seek to balance those interests to protect the proprietary nature of the trading strategies and implementation thereof by the Funds.
 
Generally, the policies prohibit the release of information concerning portfolio holdings, which have not previously been made public, to individual investors, institutional investors, intermediaries that distribute the Funds’ shares and other parties which are not employed by the Investment Manager or its affiliates except when the legitimate business purposes for selective disclosure and other conditions (designed to protect the Funds) are acceptable.
 
The Funds file their complete schedules of portfolio holdings with the SEC semi-annually in shareholder reports on Form N-CSR and after the first and third fiscal quarters as an exhibit to their reports on Form N-PORT. The Funds' Forms N-CSR and N-PORT are available online on the SEC's website at www.sec.gov.
 
In addition, the Funds make publicly available their month-end top 10 holdings with a 10 day lag and their month-end full portfolios with a 60 day lag on their website www.alger. com and through other marketing communications (including printed advertising/sales literature and/or shareholder telephone customer service centers). No compensation or other consideration is directly received for the non-public disclosure of portfolio holdings information.
 
In accordance with the foregoing, the Funds provide portfolio holdings information to third parties including financial intermediaries and service providers who need access to this information in the performance of their services and are subject to duties of confidentiality
(1) imposed by law, including a duty not to trade on non-public information, and/or (2) pursuant to an agreement that confidential information is not to be disclosed or used (including trading on such information) other than as required by law. From time to time, the Funds will communicate with these third parties to confirm that they understand      the Funds’ policies and procedures regarding such disclosure. These agreements must be approved by the Trust's Chief Compliance Officer.
 
The Board periodically reviews a report disclosing the third parties to whom each Fund’s holdings information has been disclosed and the purpose for such disclosure, and it considers whether or not the release of information to such third parties is in the best interest of the Fund and its shareholders.

THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)

 
In addition to material the Funds routinely provide to shareholders, the Investment Manager may make additional statistical information available regarding the Alger Family of Funds. Such information may include, but not be limited to, relative weightings and characteristics of a Fund versus an index (such as P/E ratio, alpha, beta, capture ratio, maximum drawdown, standard deviation, EPS forecasts, Sharpe ratio, information ratio, R-squared, and market cap analysis), security specific impact on overall portfolio performance, month-end top  ten contributors to and detractors from performance, portfolio turnover, and other similar information. Shareholders should visit www.alger.com or may also contact the Funds at (800) 992-3863 to obtain such information.
 
Liquidity Risk Management Program          

In accordance with Rule 22e-4 under the 1940 Act (the "Liquidity Rule"), the Trust has adopted and implemented a liquidity risk management program (the "LRMP"), which is reasonably designed to assess and manage the Funds’ liquidity risk.
 
The Board met on December 15, 2021 (the "Meeting") to review the LRMP. The Board previously appointed Alger Management as the program administrator for the LRMP and approved an agreement with ICE Data Services ("ICE"), a third party vendor that assists the Funds with liquidity classifications required by the Liquidity Rule. Alger Management also previously delegated oversight of the LRMP to the Liquidity Risk Committee. At the Meeting, the Liquidity Risk Committee, on behalf of Alger Management, provided the Board with a report that addressed the operation of the LRMP and assessed its adequacy and effectiveness of implementation, and any material changes to the LRMP (the "Report"). The Report covered the period from December 1, 2020 through November 30, 2021 (the “Review Period”).
 
The Report stated that the Committee assessed the Funds’ liquidity risk by considering qualitative factors such as the Funds' investment strategy, holdings, diversification of investments, redemption policies, cash flows, cash levels, shareholder concentration, and access to borrowings, among others, in conjunction with the quantitative classifications generated by ICE. In addition, in connection with the review of the Funds' liquidity risks and the operation of the LRMP and the adequacy and effectiveness of its implementation, the Liquidity Risk Committee also evaluated the levels at which to set the reasonably anticipated trade size and market price impact. The Report described the process for determining   that the Funds primarily holds investments that are highly liquid. The Report noted that the Liquidity Risk Committee also performed stress tests on certain Funds in light of the market volatility caused by the COVID-19 pandemic, and it was concluded that the Funds remained primarily highly liquid.
 
There were no material changes to the LRMP during the Review Period, except that certain changes were made to the LRMP to add liquidity considerations for certain exchange-traded funds managed by Alger Management. The Report provided to the Board stated that the Committee concluded that, based on the operation of the functions, as described in the Report, during the Review Period, the Trust's LRMP was operating effectively and adequately with respect to the Funds and has been effectively implemented during the Review Period.

THE ALGER INSTITUTIONAL FUNDS          

 
100 Pearl Street, 27th Floor
New York, NY  10004
(800) 992-3863
www.alger.com
 
Investment Manager 


Fred Alger Management, LLC
100 Pearl Street, 27th Floor
New York, NY 10004
 
Distributor          

 
Fred Alger & Company, LLC
100 Pearl Street, 27th Floor
New York, NY 10004
 
Transfer Agent and Dividend Disbursing Agent 

        
UMB Fund Services, Inc.
235 W. Galena Street
Milwaukee, WI 53212
 
Custodian          

 
Brown Brothers Harriman & Company
50 Post Office Square
Boston, MA 02110
 
Independent Registered Public Accounting Firm          


Deloitte & Touche LLP
30 Rockefeller Plaza
New York, NY 10112
 
This report is submitted for the general information of the shareholders of The Alger Institutional Funds. It is not authorized for distribution to prospective investors unless accompanied by an effective Prospectus for the Trust, which contains information concerning the Trust's investment policies, fees and expenses as well as other pertinent information.

(This page has been intentionally left blank)

(This page has been intentionally left blank)

(This page has been intentionally left blank)

(This page has been intentionally left blank)

(This page has been intentionally left blank)

(This page has been intentionally left blank)



Table of Contents
(b)
Include a copy of each notice transmitted to stockholders in reliance on Rule 30e-3 under the Act (17 CFR 270.30e-3) that contains disclosures specified by paragraph (c)(3) of that rule.
 
Not applicable.

ITEM 2.
CODE OF ETHICS.

Not applicable.

ITEM 3.
AUDIT COMMITTEE FINANCIAL EXPERT.

Not applicable.

ITEM 4.
PRINCIPAL ACCOUNTANT FEES AND SERVICES.

Not applicable.

ITEM 5.
AUDIT COMMITTEE OF LISTED REGISTRANTS.

Not applicable.

ITEM 6.
INVESTMENTS.

Not applicable.

ITEM 7.
DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.

Not applicable.

ITEM 8.
PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.

Not applicable.

ITEM 9.
PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.

Not applicable.

ITEM 10.
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

Not applicable.

ITEM 11.
CONTROLS AND PROCEDURES.

(a) The Registrant’s principal executive officer and principal financial officer have concluded that the Registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended) are effective based on their evaluation of the disclosure controls and procedures as of a date within 90 days of the filing date of this document.


Table of Contents
(b) No changes in the Registrant’s internal control over financial reporting occurred during the Registrant’s second fiscal quarter of the period covered by this report that materially affected, or are reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

ITEM 12.
Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable.

ITEM 13.
EXHIBITS.

(a) (1) Not applicable

(a) (2) Certifications of principal executive officer and principal financial officer as required by rule 30a-2(a) under the Investment Company Act of 1940 are attached as Exhibit 99.CERT

(a) (3) Not applicable
(a) (4) Not applicable

(b) Certifications of principal executive officer and principal financial officer as required by rule 30a-2(b) under the Investment Company Act of 1940 are attached as Exhibit 99.906CERT

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

The Alger Institutional Funds

By:
/s/ Hal Liebes
   
 
Hal Liebes
   
 
President

Date:  June 22, 2022

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By:
/s/ Hal Liebes
   
 
Hal Liebes
   
 
President

Date:  June 22, 2022

By:
/s/ Michael D. Martins
   
 
Michael D. Martins
   
 
Treasurer

Date:  June 22, 2022





Exhibit 99.CERT

Rule 30a-2(a) CERTIFICATIONS

I, Hal Liebes, certify that:
 
1. I have reviewed this report on Form N-CSR of The Alger Institutional Funds;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
 
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: June 22, 2022
 
/s/ Hal Liebes
Hal Liebes
President


Rule 30a-2(a) CERTIFICATIONS

I, Michael D. Martins, certify that:
 
1. I have reviewed this report on Form N-CSR of The Alger Institutional Funds;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
 
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: June 22, 2022
 
/s/ Michael D. Martins
Michael D. Martins
Treasurer





Exhibit 99.906CERT

Rule 30a-2(b) CERTIFICATIONS

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of The Alger Institutional Funds, do hereby certify, to such officer’s knowledge, that:

(1)
The semi-annual report on Form N-CSR of the Registrant for the period ended April 30, 2022 (the “Form N-CSR”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and
(2)
the information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of The Alger Institutional Funds.

Dated: June 22, 2022

/s/ Hal Liebes

Hal Liebes
President
The Alger Institutional Funds

Dated: June 22, 2022

/s/ Michael D. Martins

Michael D. Martins
Treasurer
The Alger Institutional Funds

Dated: June 22, 2022

This certification is being furnished solely pursuant to 18 U.S.C. ss. 1350 and is not being filed as part of the Report or as a separate disclosure document.